Lymphatic Metastasis
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor Receptor-3
Vascular Endothelial Growth Factor D
Neoplasm Metastasis
Endothelium, Lymphatic
Lymph Nodes
Neovascularization, Pathologic
Immunohistochemistry
Corneal Neovascularization
Endothelial Cells
Prognosis
Neoplasm Staging
Mice, Nude
Tumor Markers, Biological
Gene Expression Regulation, Neoplastic
Vascular Endothelial Growth Factor Receptor-2
Lymph Node Excision
Vascular Endothelial Growth Factor A
Melanoma, Experimental
Carcinoma, Squamous Cell
Carcinoma
Lymphography
Melanoma
Colorectal Neoplasms
Cell Movement
Neuropilin-2
Reverse Transcriptase Polymerase Chain Reaction
Fibrosarcoma
Pancreatic Neoplasms
Mice, Inbred C57BL
Neoplasm Transplantation
Mycoplasma pulmonis
Survival Rate
Signal Transduction
RNA, Messenger
Lymphangioma
Antigens, CD31
Mice, Inbred BALB C
Elephantiasis, Filarial
Neoplasms
Brain Neoplasms
Disease Progression
Cornea
Retrospective Studies
Receptors, Vascular Endothelial Growth Factor
Sentinel Lymph Node Biopsy
Lymphatic Abnormalities
Mice, SCID
Endothelial Growth Factors
Blood Vessels
Mammary Neoplasms, Experimental
Receptors, Growth Factor
Vesicular Transport Proteins
Mice, Transgenic
Neovascularization, Physiologic
Disease Models, Animal
Glycoproteins
Survival Analysis
Neoplasm Recurrence, Local
Chi-Square Distribution
Spinal Neoplasms
Mesentery
Tumor Cells, Cultured
Tomography, X-Ray Computed
Corneal Transplantation
Carcinoma, Lewis Lung
Neoplasm Micrometastasis
Immunoenzyme Techniques
Treatment Outcome
Tumor Burden
Inflammation
Skin
Xenograft Model Antitumor Assays
Antigens, CD11b
Kaplan-Meier Estimate
Fatal Outcome
Tail
Etodolac
Angiogenesis Inhibitors
Up-Regulation
NM23 Nucleoside Diphosphate Kinases
Neoplastic Cells, Circulating
Combined Modality Therapy
Tumor Suppressor Proteins
Carcinoma, Ductal, Breast
Epithelial-Mesenchymal Transition
RNA, Small Interfering
Osteosarcoma
Blotting, Western
Neoplasm Proteins
Follow-Up Studies
Macrophages
Disease-Free Survival
Angiopoietin-2
Diagnostic Imaging
Receptor Protein-Tyrosine Kinases
Gene Expression Profiling
Wuchereria bancrofti
Carcinoma, Renal Cell
Head and Neck Neoplasms
Antibodies, Monoclonal, Murine-Derived
Microvessels
Neoplasms, Experimental
Carcinoma, Papillary
Lymphatic Vessel Tumors
Endothelium, Vascular
Cadherins
Granulation Tissue
Muscle Neoplasms
Models, Biological
Radiosurgery
Lymphangiogenesis is the formation of new lymphatic vessels from pre-existing ones. It is a complex biological process that involves the growth, differentiation, and remodeling of lymphatic endothelial cells, which line the interior surface of lymphatic vessels. Lymphangiogenesis plays crucial roles in various physiological processes, including tissue drainage, immune surveillance, and lipid absorption. However, it can also contribute to pathological conditions such as cancer metastasis, inflammation, and fibrosis when it is dysregulated.
The process of lymphangiogenesis is regulated by a variety of growth factors, receptors, and signaling molecules, including vascular endothelial growth factor (VEGF)-C, VEGF-D, and their receptor VEGFR-3, as well as other factors such as angiopoietins, integrins, and matrix metalloproteinases. Understanding the mechanisms of lymphangiogenesis has important implications for developing novel therapies for a range of diseases associated with abnormal lymphatic vessel growth and function.
Lymphatic metastasis is the spread of cancer cells from a primary tumor to distant lymph nodes through the lymphatic system. It occurs when malignant cells break away from the original tumor, enter the lymphatic vessels, and travel to nearby or remote lymph nodes. Once there, these cancer cells can multiply and form new tumors, leading to further progression of the disease. Lymphatic metastasis is a common way for many types of cancer to spread and can have significant implications for prognosis and treatment strategies.
Lymphatic vessels are thin-walled, valved structures that collect and transport lymph, a fluid derived from the interstitial fluid surrounding the cells, throughout the lymphatic system. They play a crucial role in immune function and maintaining fluid balance in the body. The primary function of lymphatic vessels is to return excess interstitial fluid, proteins, waste products, and immune cells to the bloodstream via the subclavian veins near the heart.
There are two types of lymphatic vessels:
1. Lymphatic capillaries: These are the smallest lymphatic vessels, found in most body tissues except for the central nervous system (CNS). They have blind ends and are highly permeable to allow the entry of interstitial fluid, proteins, and other large molecules.
2. Larger lymphatic vessels: These include precollecting vessels, collecting vessels, and lymphatic trunks. Precollecting vessels have valves that prevent backflow of lymph and merge to form larger collecting vessels. Collecting vessels contain smooth muscle in their walls, which helps to propel the lymph forward. They also have valves at regular intervals to ensure unidirectional flow towards the heart. Lymphatic trunks are large vessels that collect lymph from various regions of the body and eventually drain into the two main lymphatic ducts: the thoracic duct and the right lymphatic duct.
Overall, lymphatic vessels play a vital role in maintaining fluid balance, immune surveillance, and waste removal in the human body.
Vascular Endothelial Growth Factor C (VEGF-C) is a protein that belongs to the family of vascular endothelial growth factors. It plays a crucial role in angiogenesis, which is the formation of new blood vessels from pre-existing ones. Specifically, VEGF-C is a key regulator of lymphangiogenesis, which is the development of new lymphatic vessels.
VEGF-C stimulates the growth and proliferation of lymphatic endothelial cells, leading to an increase in the number and size of lymphatic vessels. This process is important for maintaining fluid balance in tissues and for the immune system's response to infection and inflammation.
Abnormal regulation of VEGF-C has been implicated in various diseases, including cancer, where it can promote tumor growth and metastasis by enhancing the formation of new blood vessels that supply nutrients and oxygen to the tumor. Inhibitors of VEGF-C have been developed as potential therapeutic agents for cancer treatment.
The lymphatic system is a complex network of organs, tissues, vessels, and cells that work together to defend the body against infectious diseases and also play a crucial role in the immune system. It is made up of:
1. Lymphoid Organs: These include the spleen, thymus, lymph nodes, tonsils, adenoids, and Peyer's patches (in the intestines). They produce and mature immune cells.
2. Lymphatic Vessels: These are thin tubes that carry clear fluid called lymph towards the heart.
3. Lymph: This is a clear-to-white fluid that contains white blood cells, mainly lymphocytes, which help fight infections.
4. Other tissues and cells: These include bone marrow where immune cells are produced, and lymphocytes (T cells and B cells) which are types of white blood cells that help protect the body from infection and disease.
The primary function of the lymphatic system is to transport lymph throughout the body, collecting waste products, bacteria, viruses, and other foreign substances from the tissues, and filtering them out through the lymph nodes. The lymphatic system also helps in the absorption of fats and fat-soluble vitamins from food in the digestive tract.
Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) is a type of receptor tyrosine kinase that is primarily expressed in lymphatic endothelial cells. It is a crucial regulator of lymphangiogenesis, which is the formation of new lymphatic vessels from pre-existing ones. VEGFR-3 binds to its ligands, including VEGF-C and VEGF-D, leading to the activation of downstream signaling pathways that promote cell survival, proliferation, migration, and differentiation of lymphatic endothelial cells.
VEGFR-3 also plays a role in angiogenesis, which is the formation of new blood vessels from pre-existing ones. However, its functions in angiogenesis are less well understood compared to its roles in lymphangiogenesis. Dysregulation of VEGFR-3 signaling has been implicated in various pathological conditions, including cancer, inflammation, and lymphatic disorders.
Vascular Endothelial Growth Factor D (VEGFD) is a protein that belongs to the family of vascular endothelial growth factors. It plays an essential role in the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. Specifically, VEGFD stimulates the growth and proliferation of lymphatic endothelial cells, thereby promoting the development and maintenance of the lymphatic system.
VEGFD binds to its specific receptor, VEGFR-3, which is primarily expressed on the surface of lymphatic endothelial cells. This binding triggers a cascade of intracellular signaling events that ultimately lead to the activation of various genes involved in cell proliferation, migration, and survival.
Dysregulation of VEGFD and its receptor has been implicated in several pathological conditions, including lymphatic malformations, cancer, and inflammatory diseases. In these contexts, the overexpression or aberrant activation of VEGFD can contribute to excessive angiogenesis and lymphangiogenesis, leading to tissue edema, tumor growth, and metastasis. Therefore, targeting the VEGFD signaling pathway has emerged as a promising therapeutic strategy for various diseases.
Neoplasm metastasis is the spread of cancer cells from the primary site (where the original or primary tumor formed) to other places in the body. This happens when cancer cells break away from the original (primary) tumor and enter the bloodstream or lymphatic system. The cancer cells can then travel to other parts of the body and form new tumors, called secondary tumors or metastases.
Metastasis is a key feature of malignant neoplasms (cancers), and it is one of the main ways that cancer can cause harm in the body. The metastatic tumors may continue to grow and may cause damage to the organs and tissues where they are located. They can also release additional cancer cells into the bloodstream or lymphatic system, leading to further spread of the cancer.
The metastatic tumors are named based on the location where they are found, as well as the type of primary cancer. For example, if a patient has a primary lung cancer that has metastasized to the liver, the metastatic tumor would be called a liver metastasis from lung cancer.
It is important to note that the presence of metastases can significantly affect a person's prognosis and treatment options. In general, metastatic cancer is more difficult to treat than cancer that has not spread beyond its original site. However, there are many factors that can influence a person's prognosis and response to treatment, so it is important for each individual to discuss their specific situation with their healthcare team.
The endothelium is a thin layer of cells that lines the interior surface of blood vessels and lymphatic vessels. The lymphatic endothelium, specifically, is the type of endothelial cell that forms the walls of lymphatic vessels. These vessels are an important part of the immune system and play a crucial role in transporting fluid, waste products, and immune cells throughout the body.
The lymphatic endothelium helps to regulate the movement of fluids and cells between the tissues and the bloodstream. It also contains specialized structures called valves that help to ensure the unidirectional flow of lymph fluid towards the heart. Dysfunction of the lymphatic endothelium has been implicated in a variety of diseases, including lymphedema, inflammation, and cancer metastasis.
Lymph nodes are small, bean-shaped organs that are part of the immune system. They are found throughout the body, especially in the neck, armpits, groin, and abdomen. Lymph nodes filter lymph fluid, which carries waste and unwanted substances such as bacteria, viruses, and cancer cells. They contain white blood cells called lymphocytes that help fight infections and diseases by attacking and destroying the harmful substances found in the lymph fluid. When an infection or disease is present, lymph nodes may swell due to the increased number of immune cells and fluid accumulation as they work to fight off the invaders.
Neoplasm invasiveness is a term used in pathology and oncology to describe the aggressive behavior of cancer cells as they invade surrounding tissues and organs. This process involves the loss of cell-to-cell adhesion, increased motility and migration, and the ability of cancer cells to degrade the extracellular matrix (ECM) through the production of enzymes such as matrix metalloproteinases (MMPs).
Invasive neoplasms are cancers that have spread beyond the original site where they first developed and have infiltrated adjacent tissues or structures. This is in contrast to non-invasive or in situ neoplasms, which are confined to the epithelial layer where they originated and have not yet invaded the underlying basement membrane.
The invasiveness of a neoplasm is an important prognostic factor in cancer diagnosis and treatment, as it can indicate the likelihood of metastasis and the potential effectiveness of various therapies. In general, more invasive cancers are associated with worse outcomes and require more aggressive treatment approaches.
Pathologic neovascularization is the abnormal growth of new blood vessels in previously avascular tissue or excessive growth within existing vasculature, which occurs as a result of hypoxia, inflammation, or angiogenic stimuli. These newly formed vessels are often disorganized, fragile, and lack proper vessel hierarchy, leading to impaired blood flow and increased vascular permeability. Pathologic neovascularization can be observed in various diseases such as cancer, diabetic retinopathy, age-related macular degeneration, and chronic inflammation. This process contributes to disease progression by promoting tumor growth, metastasis, and edema formation, ultimately leading to tissue damage and organ dysfunction.
A cell line that is derived from tumor cells and has been adapted to grow in culture. These cell lines are often used in research to study the characteristics of cancer cells, including their growth patterns, genetic changes, and responses to various treatments. They can be established from many different types of tumors, such as carcinomas, sarcomas, and leukemias. Once established, these cell lines can be grown and maintained indefinitely in the laboratory, allowing researchers to conduct experiments and studies that would not be feasible using primary tumor cells. It is important to note that tumor cell lines may not always accurately represent the behavior of the original tumor, as they can undergo genetic changes during their time in culture.
Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.
Lung neoplasms refer to abnormal growths or tumors in the lung tissue. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant lung neoplasms are further classified into two main types: small cell lung carcinoma and non-small cell lung carcinoma. Lung neoplasms can cause symptoms such as cough, chest pain, shortness of breath, and weight loss. They are often caused by smoking or exposure to secondhand smoke, but can also occur due to genetic factors, radiation exposure, and other environmental carcinogens. Early detection and treatment of lung neoplasms is crucial for improving outcomes and survival rates.
Stomach neoplasms refer to abnormal growths in the stomach that can be benign or malignant. They include a wide range of conditions such as:
1. Gastric adenomas: These are benign tumors that develop from glandular cells in the stomach lining.
2. Gastrointestinal stromal tumors (GISTs): These are rare tumors that can be found in the stomach and other parts of the digestive tract. They originate from the stem cells in the wall of the digestive tract.
3. Leiomyomas: These are benign tumors that develop from smooth muscle cells in the stomach wall.
4. Lipomas: These are benign tumors that develop from fat cells in the stomach wall.
5. Neuroendocrine tumors (NETs): These are tumors that develop from the neuroendocrine cells in the stomach lining. They can be benign or malignant.
6. Gastric carcinomas: These are malignant tumors that develop from the glandular cells in the stomach lining. They are the most common type of stomach neoplasm and include adenocarcinomas, signet ring cell carcinomas, and others.
7. Lymphomas: These are malignant tumors that develop from the immune cells in the stomach wall.
Stomach neoplasms can cause various symptoms such as abdominal pain, nausea, vomiting, weight loss, and difficulty swallowing. The diagnosis of stomach neoplasms usually involves a combination of imaging tests, endoscopy, and biopsy. Treatment options depend on the type and stage of the neoplasm and may include surgery, chemotherapy, radiation therapy, or targeted therapy.
Corneal neovascularization is a medical condition that refers to the growth of new, abnormal blood vessels in the cornea, which is the clear, dome-shaped surface at the front of the eye. The cornea typically receives its nutrients from tears and oxygen in the air, so it does not have its own blood vessels. However, when the cornea is damaged or inflamed, it may trigger the growth of new blood vessels from the surrounding tissue into the cornea to promote healing.
Corneal neovascularization can occur due to various eye conditions such as infection, injury, inflammation, degenerative diseases, or contact lens wear. Excessive growth of blood vessels in the cornea can interfere with vision, cause scarring, and increase the risk of corneal transplant rejection. Treatment for corneal neovascularization depends on the underlying cause and may include topical medications, surgery, or other therapies to reduce inflammation, prevent further growth of blood vessels, and preserve vision.
Adenocarcinoma is a type of cancer that arises from glandular epithelial cells. These cells line the inside of many internal organs, including the breasts, prostate, colon, and lungs. Adenocarcinomas can occur in any of these organs, as well as in other locations where glands are present.
The term "adenocarcinoma" is used to describe a cancer that has features of glandular tissue, such as mucus-secreting cells or cells that produce hormones. These cancers often form glandular structures within the tumor mass and may produce mucus or other substances.
Adenocarcinomas are typically slow-growing and tend to spread (metastasize) to other parts of the body through the lymphatic system or bloodstream. They can be treated with surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The prognosis for adenocarcinoma depends on several factors, including the location and stage of the cancer, as well as the patient's overall health and age.
Lymphedema is a chronic condition characterized by swelling in one or more parts of the body, usually an arm or leg, due to the accumulation of lymph fluid. This occurs when the lymphatic system is unable to properly drain the fluid, often as a result of damage or removal of lymph nodes, or because of a genetic abnormality that affects lymphatic vessel development.
The swelling can range from mild to severe and may cause discomfort, tightness, or a feeling of heaviness in the affected limb. In some cases, lymphedema can also lead to skin changes, recurrent infections, and reduced mobility. The condition is currently not curable but can be managed effectively with various treatments such as compression garments, manual lymphatic drainage, exercise, and skincare routines.
Endothelial cells are the type of cells that line the inner surface of blood vessels, lymphatic vessels, and heart chambers. They play a crucial role in maintaining vascular homeostasis by controlling vasomotor tone, coagulation, platelet activation, and inflammation. Endothelial cells also regulate the transport of molecules between the blood and surrounding tissues, and contribute to the maintenance of the structural integrity of the vasculature. They are flat, elongated cells with a unique morphology that allows them to form a continuous, nonthrombogenic lining inside the vessels. Endothelial cells can be isolated from various tissues and cultured in vitro for research purposes.
Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.
Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.
Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.
Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.
The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.
Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).
In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.
Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.
Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.
"Nude mice" is a term used in the field of laboratory research to describe a strain of mice that have been genetically engineered to lack a functional immune system. Specifically, nude mice lack a thymus gland and have a mutation in the FOXN1 gene, which results in a failure to develop a mature T-cell population. This means that they are unable to mount an effective immune response against foreign substances or organisms.
The name "nude" refers to the fact that these mice also have a lack of functional hair follicles, resulting in a hairless or partially hairless phenotype. This feature is actually a secondary consequence of the same genetic mutation that causes their immune deficiency.
Nude mice are commonly used in research because their weakened immune system makes them an ideal host for transplanted tumors, tissues, and cells from other species, including humans. This allows researchers to study the behavior of these foreign substances in a living organism without the complication of an immune response. However, it's important to note that because nude mice lack a functional immune system, they must be kept in sterile conditions and are more susceptible to infection than normal mice.
Tumor markers are substances that can be found in the body and their presence can indicate the presence of certain types of cancer or other conditions. Biological tumor markers refer to those substances that are produced by cancer cells or by other cells in response to cancer or certain benign (non-cancerous) conditions. These markers can be found in various bodily fluids such as blood, urine, or tissue samples.
Examples of biological tumor markers include:
1. Proteins: Some tumor markers are proteins that are produced by cancer cells or by other cells in response to the presence of cancer. For example, prostate-specific antigen (PSA) is a protein produced by normal prostate cells and in higher amounts by prostate cancer cells.
2. Genetic material: Tumor markers can also include genetic material such as DNA, RNA, or microRNA that are shed by cancer cells into bodily fluids. For example, circulating tumor DNA (ctDNA) is genetic material from cancer cells that can be found in the bloodstream.
3. Metabolites: Tumor markers can also include metabolic products produced by cancer cells or by other cells in response to cancer. For example, lactate dehydrogenase (LDH) is an enzyme that is released into the bloodstream when cancer cells break down glucose for energy.
It's important to note that tumor markers are not specific to cancer and can be elevated in non-cancerous conditions as well. Therefore, they should not be used alone to diagnose cancer but rather as a tool in conjunction with other diagnostic tests and clinical evaluations.
Neoplastic gene expression regulation refers to the processes that control the production of proteins and other molecules from genes in neoplastic cells, or cells that are part of a tumor or cancer. In a normal cell, gene expression is tightly regulated to ensure that the right genes are turned on or off at the right time. However, in cancer cells, this regulation can be disrupted, leading to the overexpression or underexpression of certain genes.
Neoplastic gene expression regulation can be affected by a variety of factors, including genetic mutations, epigenetic changes, and signals from the tumor microenvironment. These changes can lead to the activation of oncogenes (genes that promote cancer growth and development) or the inactivation of tumor suppressor genes (genes that prevent cancer).
Understanding neoplastic gene expression regulation is important for developing new therapies for cancer, as targeting specific genes or pathways involved in this process can help to inhibit cancer growth and progression.
Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) is a tyrosine kinase receptor that is primarily expressed on vascular endothelial cells. It is a crucial regulator of angiogenesis, the process of new blood vessel formation from pre-existing vessels. VEGFR-2 is activated by binding to its ligand, Vascular Endothelial Growth Factor-A (VEGF-A), leading to receptor dimerization and autophosphorylation. This activation triggers a cascade of intracellular signaling events that promote endothelial cell proliferation, migration, survival, and vascular permeability, all essential steps in the angiogenic process.
VEGFR-2 plays a significant role in physiological and pathological conditions associated with angiogenesis, such as embryonic development, wound healing, tumor growth, and retinopathies. Inhibition of VEGFR-2 signaling has been an attractive target for anti-angiogenic therapies in various diseases, including cancer and age-related macular degeneration.
Lymph node excision is a surgical procedure in which one or more lymph nodes are removed from the body for the purpose of examination. This procedure is often conducted to help diagnose or stage various types of cancer, as malignant cells may spread to the lymphatic system and eventually accumulate within nearby lymph nodes.
During a lymph node excision, an incision is made in the skin overlying the affected lymph node(s). The surgeon carefully dissects the tissue surrounding the lymph node(s) to isolate them from adjacent structures before removing them. In some cases, a sentinel lymph node biopsy may be performed instead, where only the sentinel lymph node (the first lymph node to which cancer cells are likely to spread) is removed and examined.
The excised lymph nodes are then sent to a laboratory for histopathological examination, which involves staining and microscopic evaluation of the tissue to determine whether it contains any malignant cells. The results of this examination can help guide further treatment decisions and provide valuable prognostic information.
Vascular Endothelial Growth Factor A (VEGFA) is a specific isoform of the vascular endothelial growth factor (VEGF) family. It is a well-characterized signaling protein that plays a crucial role in angiogenesis, the process of new blood vessel formation from pre-existing vessels. VEGFA stimulates the proliferation and migration of endothelial cells, which line the interior surface of blood vessels, thereby contributing to the growth and development of new vasculature. This protein is essential for physiological processes such as embryonic development and wound healing, but it has also been implicated in various pathological conditions, including cancer, age-related macular degeneration, and diabetic retinopathy. The regulation of VEGFA expression and activity is critical to maintaining proper vascular function and homeostasis.
Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.
Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.
Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.
I cannot provide a specific medical definition for "Melanoma, Experimental," as it is not a standardized medical term. However, I can give you information about melanoma and experimental treatments related to this disease.
Melanoma is a type of cancer that develops from pigment-producing cells known as melanocytes. It usually occurs in the skin but can rarely occur in other parts of the body, such as the eyes or internal organs. Melanoma is characterized by the uncontrolled growth and multiplication of melanocytes, forming malignant tumors.
Experimental treatments for melanoma refer to novel therapeutic strategies that are currently being researched and tested in clinical trials. These experimental treatments may include:
1. Targeted therapies: Drugs that target specific genetic mutations or molecular pathways involved in melanoma growth and progression. Examples include BRAF and MEK inhibitors, such as vemurafenib, dabrafenib, and trametinib.
2. Immunotherapies: Treatments designed to enhance the immune system's ability to recognize and destroy cancer cells. These may include checkpoint inhibitors (e.g., ipilimumab, nivolumab, pembrolizumab), adoptive cell therapies (e.g., CAR T-cell therapy), and therapeutic vaccines.
3. Oncolytic viruses: Genetically modified viruses that can selectively infect and kill cancer cells while leaving healthy cells unharmed. Talimogene laherparepvec (T-VEC) is an example of an oncolytic virus approved for the treatment of advanced melanoma.
4. Combination therapies: The use of multiple experimental treatments in combination to improve efficacy and reduce the risk of resistance. For instance, combining targeted therapies with immunotherapies or different types of immunotherapies.
5. Personalized medicine approaches: Using genetic testing and biomarker analysis to identify the most effective treatment for an individual patient based on their specific tumor characteristics.
It is essential to consult with healthcare professionals and refer to clinical trial databases, such as ClinicalTrials.gov, for up-to-date information on experimental treatments for melanoma.
Squamous cell carcinoma is a type of skin cancer that begins in the squamous cells, which are flat, thin cells that form the outer layer of the skin (epidermis). It commonly occurs on sun-exposed areas such as the face, ears, lips, and backs of the hands. Squamous cell carcinoma can also develop in other areas of the body including the mouth, lungs, and cervix.
This type of cancer usually develops slowly and may appear as a rough or scaly patch of skin, a red, firm nodule, or a sore or ulcer that doesn't heal. While squamous cell carcinoma is not as aggressive as some other types of cancer, it can metastasize (spread) to other parts of the body if left untreated, making early detection and treatment important.
Risk factors for developing squamous cell carcinoma include prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, fair skin, a history of sunburns, a weakened immune system, and older age. Prevention measures include protecting your skin from the sun by wearing protective clothing, using a broad-spectrum sunscreen with an SPF of at least 30, avoiding tanning beds, and getting regular skin examinations.
Carcinoma is a type of cancer that develops from epithelial cells, which are the cells that line the inner and outer surfaces of the body. These cells cover organs, glands, and other structures within the body. Carcinomas can occur in various parts of the body, including the skin, lungs, breasts, prostate, colon, and pancreas. They are often characterized by the uncontrolled growth and division of abnormal cells that can invade surrounding tissues and spread to other parts of the body through a process called metastasis. Carcinomas can be further classified based on their appearance under a microscope, such as adenocarcinoma, squamous cell carcinoma, and basal cell carcinoma.
Lymphography is not a commonly used term in current medical practice. However, historically, it referred to a radiographic imaging technique that involved the injection of a contrast material into the lymphatic system to visualize the lymph nodes and lymph vessels. This procedure was used primarily for diagnostic purposes, particularly in the evaluation of cancerous conditions like lymphoma or melanoma.
The process typically involved injecting a radiopaque substance into the interstitial tissue, which would then be taken up by the lymphatic vessels and transported to the regional lymph nodes. X-ray imaging was used to track the progression of the contrast material, creating detailed images of the lymphatic system.
Due to advancements in medical imaging technology, lymphography has largely been replaced by other non-invasive imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. These modern methods provide high-resolution images of the body's internal structures without requiring invasive procedures or the use of contrast materials.
Melanoma is defined as a type of cancer that develops from the pigment-containing cells known as melanocytes. It typically occurs in the skin but can rarely occur in other parts of the body, including the eyes and internal organs. Melanoma is characterized by the uncontrolled growth and multiplication of melanocytes, which can form malignant tumors that invade and destroy surrounding tissue.
Melanoma is often caused by exposure to ultraviolet (UV) radiation from the sun or tanning beds, but it can also occur in areas of the body not exposed to the sun. It is more likely to develop in people with fair skin, light hair, and blue or green eyes, but it can affect anyone, regardless of their skin type.
Melanoma can be treated effectively if detected early, but if left untreated, it can spread to other parts of the body and become life-threatening. Treatment options for melanoma include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, depending on the stage and location of the cancer. Regular skin examinations and self-checks are recommended to detect any changes or abnormalities in moles or other pigmented lesions that may indicate melanoma.
Colorectal neoplasms refer to abnormal growths in the colon or rectum, which can be benign or malignant. These growths can arise from the inner lining (mucosa) of the colon or rectum and can take various forms such as polyps, adenomas, or carcinomas.
Benign neoplasms, such as hyperplastic polyps and inflammatory polyps, are not cancerous but may need to be removed to prevent the development of malignant tumors. Adenomas, on the other hand, are precancerous lesions that can develop into colorectal cancer if left untreated.
Colorectal cancer is a malignant neoplasm that arises from the uncontrolled growth and division of cells in the colon or rectum. It is one of the most common types of cancer worldwide and can spread to other parts of the body through the bloodstream or lymphatic system.
Regular screening for colorectal neoplasms is recommended for individuals over the age of 50, as early detection and removal of precancerous lesions can significantly reduce the risk of developing colorectal cancer.
Cell movement, also known as cell motility, refers to the ability of cells to move independently and change their location within tissue or inside the body. This process is essential for various biological functions, including embryonic development, wound healing, immune responses, and cancer metastasis.
There are several types of cell movement, including:
1. **Crawling or mesenchymal migration:** Cells move by extending and retracting protrusions called pseudopodia or filopodia, which contain actin filaments. This type of movement is common in fibroblasts, immune cells, and cancer cells during tissue invasion and metastasis.
2. **Amoeboid migration:** Cells move by changing their shape and squeezing through tight spaces without forming protrusions. This type of movement is often observed in white blood cells (leukocytes) as they migrate through the body to fight infections.
3. **Pseudopodial extension:** Cells extend pseudopodia, which are temporary cytoplasmic projections containing actin filaments. These protrusions help the cell explore its environment and move forward.
4. **Bacterial flagellar motion:** Bacteria use a whip-like structure called a flagellum to propel themselves through their environment. The rotation of the flagellum is driven by a molecular motor in the bacterial cell membrane.
5. **Ciliary and ependymal movement:** Ciliated cells, such as those lining the respiratory tract and fallopian tubes, have hair-like structures called cilia that beat in coordinated waves to move fluids or mucus across the cell surface.
Cell movement is regulated by a complex interplay of signaling pathways, cytoskeletal rearrangements, and adhesion molecules, which enable cells to respond to environmental cues and navigate through tissues.
Neuropilin-2 is a protein in humans that is encoded by the NRP2 gene. It is a transmembrane glycoprotein receptor that is widely expressed in various tissues, including the nervous system, endothelium, and certain types of cancer cells. Neuropilin-2 plays important roles in the development and function of the nervous system, such as axon guidance and neuronal migration. It also functions as a co-receptor for semaphorins, a family of proteins that are involved in the regulation of cell growth, differentiation, and migration. In addition to its role in the nervous system, Neuropilin-2 has been implicated in the regulation of immune responses, angiogenesis, and tumorigenesis.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.
The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.
In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.
RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.
Fibrosarcoma is a type of soft tissue cancer that develops in the fibrous (or connective) tissue found throughout the body, including tendons, ligaments, and muscles. It is characterized by the malignant proliferation of fibroblasts, which are the cells responsible for producing collagen, a structural protein found in connective tissue.
The tumor typically presents as a painless, firm mass that grows slowly over time. Fibrosarcomas can occur at any age but are more common in adults between 30 and 60 years old. The exact cause of fibrosarcoma is not well understood, but it has been linked to radiation exposure, certain chemicals, and genetic factors.
There are several subtypes of fibrosarcoma, including adult-type fibrosarcoma, infantile fibrosarcoma, and dedifferentiated fibrosarcoma. Treatment usually involves surgical removal of the tumor, often followed by radiation therapy and/or chemotherapy to reduce the risk of recurrence. The prognosis for patients with fibrosarcoma depends on several factors, including the size and location of the tumor, the patient's age and overall health, and the presence or absence of metastasis (spread of cancer to other parts of the body).
Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.
Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.
Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.
There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.
C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.
The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.
C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.
One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.
Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.
Neoplasm transplantation is not a recognized or established medical procedure in the field of oncology. The term "neoplasm" refers to an abnormal growth of cells, which can be benign or malignant (cancerous). "Transplantation" typically refers to the surgical transfer of living cells, tissues, or organs from one part of the body to another or between individuals.
The concept of neoplasm transplantation may imply the transfer of cancerous cells or tissues from a donor to a recipient, which is not a standard practice due to ethical considerations and the potential harm it could cause to the recipient. In some rare instances, researchers might use laboratory animals to study the transmission and growth of human cancer cells, but this is done for scientific research purposes only and under strict regulatory guidelines.
In summary, there is no medical definition for 'Neoplasm Transplantation' as it does not represent a standard or ethical medical practice.
Lymph is a colorless, transparent fluid that circulates throughout the lymphatic system, which is a part of the immune and circulatory systems. It consists of white blood cells called lymphocytes, proteins, lipids, glucose, electrolytes, hormones, and waste products. Lymph plays an essential role in maintaining fluid balance, absorbing fats from the digestive tract, and defending the body against infection by transporting immune cells to various tissues and organs. It is collected from tissues through lymph capillaries and flows through increasingly larger lymphatic vessels, ultimately returning to the bloodstream via the subclavian veins in the chest region.
"Mycoplasma pulmonis" is a species of bacteria that belongs to the genus Mycoplasma, which are characterized as the smallest free-living organisms. "M. pulmonis" is known to primarily infect rodents, particularly mice and rats, causing respiratory diseases. It colonizes the upper and lower respiratory tract, leading to conditions such as murine respiratory mycoplasmosis (MRM).
The bacteria lack a cell wall, which makes them resistant to many antibiotics that target cell wall synthesis. They can cause chronic inflammation and damage to the respiratory system, including airway obstruction, bronchiolitis, and alveolitis. Transmission of "M. pulmonis" typically occurs through direct contact with infected animals or their aerosolized secretions.
It is important to note that "Mycoplasma pulmonis" does not infect humans and is primarily a research model for studying bacterial respiratory infections and host immune responses.
Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.
Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.
The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.
Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.
Skin neoplasms refer to abnormal growths or tumors in the skin that can be benign (non-cancerous) or malignant (cancerous). They result from uncontrolled multiplication of skin cells, which can form various types of lesions. These growths may appear as lumps, bumps, sores, patches, or discolored areas on the skin.
Benign skin neoplasms include conditions such as moles, warts, and seborrheic keratoses, while malignant skin neoplasms are primarily classified into melanoma, squamous cell carcinoma, and basal cell carcinoma. These three types of cancerous skin growths are collectively known as non-melanoma skin cancers (NMSCs). Melanoma is the most aggressive and dangerous form of skin cancer, while NMSCs tend to be less invasive but more common.
It's essential to monitor any changes in existing skin lesions or the appearance of new growths and consult a healthcare professional for proper evaluation and treatment if needed.
Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.
Lymphangioma is a benign (noncancerous) tumor or malformation that occurs due to the abnormal development of the lymphatic system, a part of the immune system that helps fight infection and eliminate waste products. Lymphangiomas are typically composed of dilated lymphatic vessels filled with clear fluid called lymph. These masses can occur in various parts of the body but are most commonly found in the head, neck, and axilla (armpit) regions.
There are three main types of lymphangiomas:
1. Capillary lymphangioma: Also known as "lymphangiectasia" or "lymphangiomatosis," this is the most superficial and least aggressive type, often presenting as small vesicles or blisters on the skin.
2. Cavernous lymphangioma: This type consists of larger, more dilated lymphatic spaces and can involve deeper tissues. It usually appears as a soft, compressible mass beneath the skin.
3. Cystic hygroma: A subtype of cavernous lymphangioma, cystic hygromas are typically found in the neck or axilla regions and present as large, fluid-filled sacs or cysts.
Lymphangiomas can cause various symptoms depending on their size and location, including swelling, pain, infection, difficulty swallowing, or breathing problems if they compress vital structures such as airways or blood vessels. Treatment options may include surgical excision, sclerotherapy (injection of a substance to shrink the lesion), or observation, depending on the individual case and patient's preferences.
CD31 (also known as PECAM-1 or Platelet Endothelial Cell Adhesion Molecule-1) is a type of protein that is found on the surface of certain cells in the body, including platelets, endothelial cells (which line the blood vessels), and some immune cells.
CD31 functions as a cell adhesion molecule, meaning it helps cells stick together and interact with each other. It plays important roles in various physiological processes, such as the regulation of leukocyte migration, angiogenesis (the formation of new blood vessels), hemostasis (the process that stops bleeding), and thrombosis (the formation of a blood clot inside a blood vessel).
As an antigen, CD31 is used in immunological techniques to identify and characterize cells expressing this protein. Antigens are substances that can be recognized by the immune system and stimulate an immune response. In the case of CD31, antibodies specific to this protein can be used to detect its presence on the surface of cells, providing valuable information for research and diagnostic purposes.
BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.
BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.
One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.
BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.
Cell proliferation is the process by which cells increase in number, typically through the process of cell division. In the context of biology and medicine, it refers to the reproduction of cells that makes up living tissue, allowing growth, maintenance, and repair. It involves several stages including the transition from a phase of quiescence (G0 phase) to an active phase (G1 phase), DNA replication in the S phase, and mitosis or M phase, where the cell divides into two daughter cells.
Abnormal or uncontrolled cell proliferation is a characteristic feature of many diseases, including cancer, where deregulated cell cycle control leads to excessive and unregulated growth of cells, forming tumors that can invade surrounding tissues and metastasize to distant sites in the body.
Elephantiasis, filarial is a medical condition characterized by the severe swelling of limbs or other parts of the body due to the blockage of lymphatic vessels by parasitic worms. It is caused by infection with threadlike nematode filarial worms, such as Wuchereria bancrofti and Brugia timori. These worms are transmitted to humans through mosquito bites.
The blockage of lymphatic vessels leads to the accumulation of lymph fluid in the affected area, causing progressive swelling, thickening, and hardening of the skin and underlying tissues. In advanced cases, the skin may become rough, nodular, and fissured, resembling the hide of an elephant, hence the name "elephantiasis."
The condition is usually chronic and can cause significant disability and social stigma. While there is no cure for filarial elephantiasis, various treatments are available to alleviate symptoms, prevent transmission, and halt the progression of the disease. These include antibiotics to kill the worms, surgery to remove the lymphatic obstruction, and various supportive measures to manage the swelling and prevent secondary infections.
Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.
Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.
Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.
Brain neoplasms, also known as brain tumors, are abnormal growths of cells within the brain. These growths can be benign (non-cancerous) or malignant (cancerous). Benign brain tumors typically grow slowly and do not spread to other parts of the body. However, they can still cause serious problems if they press on sensitive areas of the brain. Malignant brain tumors, on the other hand, are cancerous and can grow quickly, invading surrounding brain tissue and spreading to other parts of the brain or spinal cord.
Brain neoplasms can arise from various types of cells within the brain, including glial cells (which provide support and insulation for nerve cells), neurons (nerve cells that transmit signals in the brain), and meninges (the membranes that cover the brain and spinal cord). They can also result from the spread of cancer cells from other parts of the body, known as metastatic brain tumors.
Symptoms of brain neoplasms may vary depending on their size, location, and growth rate. Common symptoms include headaches, seizures, weakness or paralysis in the limbs, difficulty with balance and coordination, changes in speech or vision, confusion, memory loss, and changes in behavior or personality.
Treatment for brain neoplasms depends on several factors, including the type, size, location, and grade of the tumor, as well as the patient's age and overall health. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. Regular follow-up care is essential to monitor for recurrence and manage any long-term effects of treatment.
Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.
The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.
In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.
The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.
Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.
Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.
Vascular endothelial growth factor (VEGF) receptors are a type of cell surface receptor that play crucial roles in the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. These receptors bind to VEGF proteins, leading to a cascade of intracellular signaling events that ultimately result in the proliferation, migration, and survival of endothelial cells, which line the interior surface of blood vessels. There are three main types of VEGF receptors: VEGFR-1, VEGFR-2, and VEGFR-3. These receptors have distinct roles in angiogenesis, with VEGFR-2 being the primary mediator of this process. Dysregulation of VEGF signaling has been implicated in various diseases, including cancer, age-related macular degeneration, and diabetic retinopathy, making VEGF receptors important targets for therapeutic intervention.
A sentinel lymph node biopsy is a surgical procedure used in cancer staging to determine if the cancer has spread beyond the primary tumor to the lymphatic system. This procedure involves identifying and removing the sentinel lymph node(s), which are the first few lymph nodes to which cancer cells are most likely to spread from the primary tumor site.
The sentinel lymph node(s) are identified by injecting a tracer substance (usually a radioactive material and/or a blue dye) near the tumor site. The tracer substance is taken up by the lymphatic vessels and transported to the sentinel lymph node(s), allowing the surgeon to locate and remove them.
The removed sentinel lymph node(s) are then examined under a microscope for the presence of cancer cells. If no cancer cells are found, it is unlikely that the cancer has spread to other lymph nodes or distant sites in the body. However, if cancer cells are present, further lymph node dissection and/or additional treatment may be necessary.
Sentinel lymph node biopsy is commonly used in the staging of melanoma, breast cancer, and some types of head and neck cancer.
Lymphatic abnormalities refer to conditions or defects that affect the lymphatic system, which is a part of the immune and circulatory systems. The lymphatic system includes a network of vessels, tissues, and organs that help rid the body of waste and toxins, fight infections, and maintain fluid balance.
Lymphatic abnormalities can occur due to genetic mutations, infections, inflammation, or cancer. These abnormalities may affect various components of the lymphatic system, including:
1. Lymph vessels: Abnormalities in lymph vessels can lead to a buildup of lymph fluid in certain parts of the body, causing swelling known as lymphedema.
2. Lymph nodes: Enlarged or abnormally shaped lymph nodes (lymphadenopathy) may indicate an infection, inflammation, or cancer.
3. Spleen: An enlarged spleen (splenomegaly) can be a sign of various conditions, such as infections, blood disorders, or cancer.
4. Thymus: Abnormalities in the thymus gland, which is part of the immune system, can lead to immunodeficiency disorders.
5. Tonsils and adenoids: Enlarged tonsils and adenoids can cause breathing and swallowing difficulties, especially in children.
6. Aggregated lymphatic tissue: Abnormalities in aggregated lymphatic tissue, such as Peyer's patches in the small intestine or the appendix, can increase the risk of infections and autoimmune disorders.
Lymphatic abnormalities can present with various symptoms, including swelling, pain, recurrent infections, and fatigue. Treatment depends on the underlying cause and may involve medications, surgery, or lifestyle changes.
SCID mice is an acronym for Severe Combined Immunodeficiency mice. These are genetically modified mice that lack a functional immune system due to the mutation or knockout of several key genes required for immunity. This makes them ideal for studying the human immune system, infectious diseases, and cancer, as well as testing new therapies and treatments in a controlled environment without the risk of interference from the mouse's own immune system. SCID mice are often used in xenotransplantation studies, where human cells or tissues are transplanted into the mouse to study their behavior and interactions with the human immune system.
Heterologous transplantation is a type of transplantation where an organ or tissue is transferred from one species to another. This is in contrast to allogeneic transplantation, where the donor and recipient are of the same species, or autologous transplantation, where the donor and recipient are the same individual.
In heterologous transplantation, the immune systems of the donor and recipient are significantly different, which can lead to a strong immune response against the transplanted organ or tissue. This is known as a graft-versus-host disease (GVHD), where the immune cells in the transplanted tissue attack the recipient's body.
Heterologous transplantation is not commonly performed in clinical medicine due to the high risk of rejection and GVHD. However, it may be used in research settings to study the biology of transplantation and to develop new therapies for transplant rejection.
Endothelial growth factors (ECGFs or EGFs) are a group of signaling proteins that stimulate the growth, proliferation, and survival of endothelial cells, which line the interior surface of blood vessels. These growth factors play crucial roles in various physiological processes, including angiogenesis (the formation of new blood vessels), wound healing, and vascular development during embryogenesis.
One of the most well-studied EGFs is the vascular endothelial growth factor (VEGF) family, which consists of several members like VEGFA, VEGFB, VEGFC, VEGFD, and placental growth factor (PlGF). These factors bind to specific receptors on the surface of endothelial cells, leading to a cascade of intracellular signaling events that ultimately result in cell proliferation, migration, and survival.
Other EGFs include fibroblast growth factors (FGFs), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF), and transforming growth factor-beta (TGF-β). Dysregulation of endothelial growth factors has been implicated in various pathological conditions, such as cancer, diabetic retinopathy, age-related macular degeneration, and cardiovascular diseases. Therefore, understanding the functions and regulation of EGFs is essential for developing novel therapeutic strategies to treat these disorders.
Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.
Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.
Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.
It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.
Blood vessels are the part of the circulatory system that transport blood throughout the body. They form a network of tubes that carry blood to and from the heart, lungs, and other organs. The main types of blood vessels are arteries, veins, and capillaries. Arteries carry oxygenated blood away from the heart to the rest of the body, while veins return deoxygenated blood back to the heart. Capillaries connect arteries and veins and facilitate the exchange of oxygen, nutrients, and waste materials between the blood and the body's tissues.
'Mammary neoplasms, experimental' is not a recognized medical term. However, I can provide definitions for the individual terms:
1. Mammary: Pertaining to the breast or mammary glands in females, which are responsible for milk production.
2. Neoplasms: Abnormal growths of tissue, also known as tumors or masses, that can be benign (non-cancerous) or malignant (cancerous).
3. Experimental: Relating to a scientific experiment or study, typically conducted in a controlled setting to test hypotheses and gather data.
In the context of medical research, 'experimental mammary neoplasms' may refer to artificially induced breast tumors in laboratory animals (such as rats or mice) for the purpose of studying the development, progression, treatment, and prevention of breast cancer. These studies can help researchers better understand the biology of breast cancer and develop new therapies and strategies for its diagnosis and management.
Growth factor receptors are a type of cell surface receptor that bind to specific growth factors, which are signaling molecules that play crucial roles in regulating various cellular processes such as growth, differentiation, and survival. These receptors have an extracellular domain that can recognize and bind to the growth factor and an intracellular domain that can transduce the signal into the cell through a series of biochemical reactions.
There are several types of growth factors, including fibroblast growth factors (FGFs), epidermal growth factors (EGFs), vascular endothelial growth factors (VEGFs), and transforming growth factors (TGFs). Each type of growth factor has its own specific receptor or family of receptors.
Once a growth factor binds to its receptor, it triggers a cascade of intracellular signaling events that ultimately lead to changes in gene expression, protein synthesis, and other cellular responses. These responses can include the activation of enzymes, the regulation of ion channels, and the modulation of cytoskeletal dynamics.
Abnormalities in growth factor receptor signaling have been implicated in various diseases, including cancer, developmental disorders, and autoimmune diseases. For example, mutations in growth factor receptors can lead to uncontrolled cell growth and division, which is a hallmark of cancer. Therefore, understanding the structure and function of growth factor receptors has important implications for the development of new therapies for these diseases.
Vesicular transport proteins are specialized proteins that play a crucial role in the intracellular trafficking and transportation of various biomolecules, such as proteins and lipids, within eukaryotic cells. These proteins facilitate the formation, movement, and fusion of membrane-bound vesicles, which are small, spherical structures that carry cargo between different cellular compartments or organelles.
There are several types of vesicular transport proteins involved in this process:
1. Coat Proteins (COPs): These proteins form a coat around the vesicle membrane and help shape it into its spherical form during the budding process. They also participate in selecting and sorting cargo for transportation. Two main types of COPs exist: COPI, which is involved in transport between the Golgi apparatus and the endoplasmic reticulum (ER), and COPII, which mediates transport from the ER to the Golgi apparatus.
2. SNARE Proteins: These proteins are responsible for the specific recognition and docking of vesicles with their target membranes. They form complexes that bring the vesicle and target membranes close together, allowing for fusion and the release of cargo into the target organelle. There are two types of SNARE proteins: v-SNAREs (vesicle SNAREs) and t-SNAREs (target SNAREs), which interact to form a stable complex during membrane fusion.
3. Rab GTPases: These proteins act as molecular switches that regulate the recruitment of coat proteins, motor proteins, and SNAREs during vesicle transport. They cycle between an active GTP-bound state and an inactive GDP-bound state, controlling the various stages of vesicular trafficking, such as budding, transport, tethering, and fusion.
4. Tethering Proteins: These proteins help to bridge the gap between vesicles and their target membranes before SNARE-mediated fusion occurs. They play a role in ensuring specificity during vesicle docking and may also contribute to regulating the timing of membrane fusion events.
5. Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptors (SNAREs): These proteins are involved in intracellular transport, particularly in the trafficking of vesicles between organelles. They consist of a family of coiled-coil domain-containing proteins that form complexes to mediate membrane fusion events.
Overall, these various classes of proteins work together to ensure the specificity and efficiency of vesicular transport in eukaryotic cells. Dysregulation or mutation of these proteins can lead to various diseases, including neurodegenerative disorders and cancer.
Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.
The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.
Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.
Physiologic neovascularization is the natural and controlled formation of new blood vessels in the body, which occurs as a part of normal growth and development, as well as in response to tissue repair and wound healing. This process involves the activation of endothelial cells, which line the interior surface of blood vessels, and their migration, proliferation, and tube formation to create new capillaries. Physiologic neovascularization is tightly regulated by a balance of pro-angiogenic and anti-angiogenic factors, ensuring that it occurs only when and where it is needed. It plays crucial roles in various physiological processes, such as embryonic development, tissue regeneration, and wound healing.
Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.
The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.
Examples of animal disease models include:
1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.
Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.
Glycoproteins are complex proteins that contain oligosaccharide chains (glycans) covalently attached to their polypeptide backbone. These glycans are linked to the protein through asparagine residues (N-linked) or serine/threonine residues (O-linked). Glycoproteins play crucial roles in various biological processes, including cell recognition, cell-cell interactions, cell adhesion, and signal transduction. They are widely distributed in nature and can be found on the outer surface of cell membranes, in extracellular fluids, and as components of the extracellular matrix. The structure and composition of glycoproteins can vary significantly depending on their function and location within an organism.
Survival analysis is a branch of statistics that deals with the analysis of time to event data. It is used to estimate the time it takes for a certain event of interest to occur, such as death, disease recurrence, or treatment failure. The event of interest is called the "failure" event, and survival analysis estimates the probability of not experiencing the failure event until a certain point in time, also known as the "survival" probability.
Survival analysis can provide important information about the effectiveness of treatments, the prognosis of patients, and the identification of risk factors associated with the event of interest. It can handle censored data, which is common in medical research where some participants may drop out or be lost to follow-up before the event of interest occurs.
Survival analysis typically involves estimating the survival function, which describes the probability of surviving beyond a certain time point, as well as hazard functions, which describe the instantaneous rate of failure at a given time point. Other important concepts in survival analysis include median survival times, restricted mean survival times, and various statistical tests to compare survival curves between groups.
Local neoplasm recurrence is the return or regrowth of a tumor in the same location where it was originally removed or treated. This means that cancer cells have survived the initial treatment and started to grow again in the same area. It's essential to monitor and detect any local recurrence as early as possible, as it can affect the prognosis and may require additional treatment.
Lymphatic diseases refer to a group of conditions that affect the lymphatic system, which is an important part of the immune and circulatory systems. The lymphatic system consists of a network of vessels, organs, and tissues that help to transport lymph fluid throughout the body, fight infection, and remove waste products.
Lymphatic diseases can be caused by various factors, including genetics, infections, cancer, and autoimmune disorders. Some common types of lymphatic diseases include:
1. Lymphedema: A condition that causes swelling in the arms or legs due to a blockage or damage in the lymphatic vessels.
2. Lymphoma: A type of cancer that affects the lymphatic system, including Hodgkin's and non-Hodgkin's lymphoma.
3. Infections: Certain bacterial and viral infections can affect the lymphatic system, such as tuberculosis, cat-scratch disease, and HIV/AIDS.
4. Autoimmune disorders: Conditions such as rheumatoid arthritis, lupus, and scleroderma can cause inflammation and damage to the lymphatic system.
5. Congenital abnormalities: Some people are born with abnormalities in their lymphatic system, such as malformations or missing lymph nodes.
Symptoms of lymphatic diseases may vary depending on the specific condition and its severity. Treatment options may include medication, physical therapy, surgery, or radiation therapy. It is important to seek medical attention if you experience symptoms of a lymphatic disease, as early diagnosis and treatment can improve outcomes.
The Chi-square distribution is a continuous probability distribution that is often used in statistical hypothesis testing. It is the distribution of a sum of squares of k independent standard normal random variables. The resulting quantity follows a chi-square distribution with k degrees of freedom, denoted as χ²(k).
The probability density function (pdf) of the Chi-square distribution with k degrees of freedom is given by:
f(x; k) = (1/ (2^(k/2) * Γ(k/2))) \* x^((k/2)-1) \* e^(-x/2), for x > 0 and 0, otherwise.
Where Γ(k/2) is the gamma function evaluated at k/2. The mean and variance of a Chi-square distribution with k degrees of freedom are k and 2k, respectively.
The Chi-square distribution has various applications in statistical inference, including testing goodness-of-fit, homogeneity of variances, and independence in contingency tables.
Spinal neoplasms refer to abnormal growths or tumors found within the spinal column, which can be benign (non-cancerous) or malignant (cancerous). These tumors can originate in the spine itself, called primary spinal neoplasms, or they can spread to the spine from other parts of the body, known as secondary or metastatic spinal neoplasms. Spinal neoplasms can cause various symptoms, such as back pain, neurological deficits, and even paralysis, depending on their location and size. Early diagnosis and treatment are crucial to prevent or minimize long-term complications and improve the patient's prognosis.
The mesentery is a continuous fold of the peritoneum, the double-layered serous membrane that lines the abdominal cavity, which attaches the stomach, small intestine, large intestine (colon), and rectum to the posterior wall of the abdomen. It provides blood vessels, nerves, and lymphatic vessels to these organs.
Traditionally, the mesentery was thought to consist of separate and distinct sections along the length of the intestines. However, recent research has shown that the mesentery is a continuous organ, with a single continuous tethering point to the posterior abdominal wall. This new understanding of the anatomy of the mesentery has implications for the study of various gastrointestinal diseases and disorders.
'Tumor cells, cultured' refers to the process of removing cancerous cells from a tumor and growing them in controlled laboratory conditions. This is typically done by isolating the tumor cells from a patient's tissue sample, then placing them in a nutrient-rich environment that promotes their growth and multiplication.
The resulting cultured tumor cells can be used for various research purposes, including the study of cancer biology, drug development, and toxicity testing. They provide a valuable tool for researchers to better understand the behavior and characteristics of cancer cells outside of the human body, which can lead to the development of more effective cancer treatments.
It is important to note that cultured tumor cells may not always behave exactly the same way as they do in the human body, so findings from cell culture studies must be validated through further research, such as animal models or clinical trials.
X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.
The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.
CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.
In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.
CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.
In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.
Corneal transplantation, also known as keratoplasty, is a surgical procedure in which all or part of a damaged or diseased cornea is replaced with healthy corneal tissue from a deceased donor. The cornea is the clear, dome-shaped surface at the front of the eye that plays an important role in focusing vision. When it becomes cloudy or misshapen due to injury, infection, or inherited conditions, vision can become significantly impaired.
During the procedure, the surgeon carefully removes a circular section of the damaged cornea and replaces it with a similarly sized piece of donor tissue. The new cornea is then stitched into place using very fine sutures that are typically removed several months after surgery.
Corneal transplantation has a high success rate, with more than 90% of procedures resulting in improved vision. However, as with any surgical procedure, there are risks involved, including infection, rejection of the donor tissue, and bleeding. Regular follow-up care is essential to monitor for any signs of complications and ensure proper healing.
In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.
For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.
Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.
Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.
I am not aware of a specific medical definition for the term "China." Generally, it is used to refer to:
1. The People's Republic of China (PRC), which is a country in East Asia. It is the most populous country in the world and the fourth largest by geographical area. Its capital city is Beijing.
2. In a historical context, "China" was used to refer to various dynasties and empires that existed in East Asia over thousands of years. The term "Middle Kingdom" or "Zhongguo" (中国) has been used by the Chinese people to refer to their country for centuries.
3. In a more general sense, "China" can also be used to describe products or goods that originate from or are associated with the People's Republic of China.
If you have a specific context in which you encountered the term "China" related to medicine, please provide it so I can give a more accurate response.
"Carcinoma, Lewis lung" is a term used to describe a specific type of lung cancer that was first discovered in strain C57BL/6J mice by Dr. Margaret R. Lewis in 1951. It is a spontaneously occurring undifferentiated carcinoma that originates from the lung epithelium and is highly invasive and metastatic, making it a popular model for studying cancer biology and testing potential therapies.
The Lewis lung carcinoma (LLC) cells are typically characterized by their rapid growth rate, ability to form tumors when implanted into syngeneic mice, and high levels of vascular endothelial growth factor (VEGF), which promotes angiogenesis and tumor growth.
It is important to note that while the LLC model has been useful for studying certain aspects of lung cancer, it may not fully recapitulate the complexity and heterogeneity of human lung cancers. Therefore, findings from LLC studies should be validated in more clinically relevant models before being translated into human therapies.
A neoplasm micrometastasis is a small focus of cancer cells that has spread (metastasized) from the primary tumor to a distant site and is too small to be detected by standard diagnostic methods, such as imaging studies or clinical examination. It is typically identified through the use of immunohistochemical stains or molecular techniques during microscopic examination of tissue samples.
Micrometastases are often found in patients with early-stage cancer and can indicate a higher risk of recurrence or metastasis. However, not all micrometastases will progress to clinical metastases, and their significance is still an area of ongoing research.
Immunoenzyme techniques are a group of laboratory methods used in immunology and clinical chemistry that combine the specificity of antibody-antigen reactions with the sensitivity and amplification capabilities of enzyme reactions. These techniques are primarily used for the detection, quantitation, or identification of various analytes (such as proteins, hormones, drugs, viruses, or bacteria) in biological samples.
In immunoenzyme techniques, an enzyme is linked to an antibody or antigen, creating a conjugate. This conjugate then interacts with the target analyte in the sample, forming an immune complex. The presence and amount of this immune complex can be visualized or measured by detecting the enzymatic activity associated with it.
There are several types of immunoenzyme techniques, including:
1. Enzyme-linked Immunosorbent Assay (ELISA): A widely used method for detecting and quantifying various analytes in a sample. In ELISA, an enzyme is attached to either the capture antibody or the detection antibody. After the immune complex formation, a substrate is added that reacts with the enzyme, producing a colored product that can be measured spectrophotometrically.
2. Immunoblotting (Western blot): A method used for detecting specific proteins in a complex mixture, such as a protein extract from cells or tissues. In this technique, proteins are separated by gel electrophoresis and transferred to a membrane, where they are probed with an enzyme-conjugated antibody directed against the target protein.
3. Immunohistochemistry (IHC): A method used for detecting specific antigens in tissue sections or cells. In IHC, an enzyme-conjugated primary or secondary antibody is applied to the sample, and the presence of the antigen is visualized using a chromogenic substrate that produces a colored product at the site of the antigen-antibody interaction.
4. Immunofluorescence (IF): A method used for detecting specific antigens in cells or tissues by employing fluorophore-conjugated antibodies. The presence of the antigen is visualized using a fluorescence microscope.
5. Enzyme-linked immunosorbent assay (ELISA): A method used for detecting and quantifying specific antigens or antibodies in liquid samples, such as serum or culture supernatants. In ELISA, an enzyme-conjugated detection antibody is added after the immune complex formation, and a substrate is added that reacts with the enzyme to produce a colored product that can be measured spectrophotometrically.
These techniques are widely used in research and diagnostic laboratories for various applications, including protein characterization, disease diagnosis, and monitoring treatment responses.
Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.
Tumor burden is a term used to describe the total amount of cancer in the body. It can refer to the number of tumors, the size of the tumors, or the amount of cancer cells in the body. In research and clinical trials, tumor burden is often measured to assess the effectiveness of treatments or to monitor disease progression. High tumor burden can cause various symptoms and complications, depending on the type and location of the cancer. It can also affect a person's prognosis and treatment options.
Inflammation is a complex biological response of tissues to harmful stimuli, such as pathogens, damaged cells, or irritants. It is characterized by the following signs: rubor (redness), tumor (swelling), calor (heat), dolor (pain), and functio laesa (loss of function). The process involves the activation of the immune system, recruitment of white blood cells, and release of inflammatory mediators, which contribute to the elimination of the injurious stimuli and initiation of the healing process. However, uncontrolled or chronic inflammation can also lead to tissue damage and diseases.
In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.
Mammary neoplasms in animals refer to abnormal growths or tumors that occur in the mammary glands. These tumors can be benign (non-cancerous) or malignant (cancerous). Benign tumors are slow growing and rarely spread to other parts of the body, while malignant tumors are aggressive, can invade surrounding tissues, and may metastasize to distant organs.
Mammary neoplasms are more common in female animals, particularly those that have not been spayed. The risk factors for developing mammary neoplasms include age, reproductive status, hormonal influences, and genetic predisposition. Certain breeds of dogs, such as poodles, cocker spaniels, and dachshunds, are more prone to developing mammary tumors.
Clinical signs of mammary neoplasms may include the presence of a firm, discrete mass in the mammary gland, changes in the overlying skin such as ulceration or discoloration, and evidence of pain or discomfort in the affected area. Diagnosis is typically made through a combination of physical examination, imaging studies (such as mammography or ultrasound), and biopsy with histopathological evaluation.
Treatment options for mammary neoplasms depend on the type, size, location, and stage of the tumor, as well as the animal's overall health status. Surgical removal is often the primary treatment modality, and may be curative for benign tumors or early-stage malignant tumors. Radiation therapy and chemotherapy may also be used in cases where the tumor has spread to other parts of the body. Regular veterinary check-ups and monitoring are essential to ensure early detection and treatment of any recurrence or new mammary neoplasms.
A xenograft model antitumor assay is a type of preclinical cancer research study that involves transplanting human tumor cells or tissues into an immunodeficient mouse. This model allows researchers to study the effects of various treatments, such as drugs or immune therapies, on human tumors in a living organism.
In this assay, human tumor cells or tissues are implanted into the mouse, typically under the skin or in another organ, where they grow and form a tumor. Once the tumor has established, the mouse is treated with the experimental therapy, and the tumor's growth is monitored over time. The response of the tumor to the treatment is then assessed by measuring changes in tumor size or weight, as well as other parameters such as survival rate and metastasis.
Xenograft model antitumor assays are useful for evaluating the efficacy and safety of new cancer therapies before they are tested in human clinical trials. They provide valuable information on how the tumors respond to treatment, drug pharmacokinetics, and toxicity, which can help researchers optimize dosing regimens and identify potential side effects. However, it is important to note that xenograft models have limitations, such as differences in tumor biology between mice and humans, and may not always predict how well a therapy will work in human patients.
CD11b, also known as integrin αM or Mac-1, is not an antigen itself but a protein that forms part of a family of cell surface receptors called integrins. These integrins play a crucial role in various biological processes, including cell adhesion, migration, and signaling.
CD11b combines with CD18 (integrin β2) to form the heterodimeric integrin αMβ2, also known as Mac-1 or CR3 (complement receptor 3). This integrin is primarily expressed on the surface of myeloid cells, such as monocytes, macrophages, and neutrophils.
As an integral part of the immune system, CD11b/CD18 recognizes and binds to various ligands, including:
1. Icosahedral bacterial components like lipopolysaccharides (LPS) and peptidoglycans
2. Fragments of complement component C3b (iC3b)
3. Fibrinogen and other extracellular matrix proteins
4. Certain immune cell receptors, such as ICAM-1 (intercellular adhesion molecule 1)
The binding of CD11b/CD18 to these ligands triggers various intracellular signaling pathways that regulate the immune response and inflammation. In this context, antigens are substances (usually proteins or polysaccharides) found on the surface of cells, viruses, or bacteria that can be recognized by the immune system. CD11b/CD18 plays a role in recognizing and responding to these antigens during an immune response.
The Kaplan-Meier estimate is a statistical method used to calculate the survival probability over time in a population. It is commonly used in medical research to analyze time-to-event data, such as the time until a patient experiences a specific event like disease progression or death. The Kaplan-Meier estimate takes into account censored data, which occurs when some individuals are lost to follow-up before experiencing the event of interest.
The method involves constructing a survival curve that shows the proportion of subjects still surviving at different time points. At each time point, the survival probability is calculated as the product of the conditional probabilities of surviving from one time point to the next. The Kaplan-Meier estimate provides an unbiased and consistent estimator of the survival function, even when censoring is present.
In summary, the Kaplan-Meier estimate is a crucial tool in medical research for analyzing time-to-event data and estimating survival probabilities over time while accounting for censored observations.
Colonic neoplasms refer to abnormal growths in the large intestine, also known as the colon. These growths can be benign (non-cancerous) or malignant (cancerous). The two most common types of colonic neoplasms are adenomas and carcinomas.
Adenomas are benign tumors that can develop into cancer over time if left untreated. They are often found during routine colonoscopies and can be removed during the procedure.
Carcinomas, on the other hand, are malignant tumors that invade surrounding tissues and can spread to other parts of the body. Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colonic neoplasms are a significant risk factor for developing this type of cancer.
Regular screenings for colonic neoplasms are recommended for individuals over the age of 50 or those with a family history of colorectal cancer or other risk factors. Early detection and removal of colonic neoplasms can significantly reduce the risk of developing colorectal cancer.
Kidney neoplasms refer to abnormal growths or tumors in the kidney tissues that can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various types of kidney cells, including the renal tubules, glomeruli, and the renal pelvis.
Malignant kidney neoplasms are also known as kidney cancers, with renal cell carcinoma being the most common type. Benign kidney neoplasms include renal adenomas, oncocytomas, and angiomyolipomas. While benign neoplasms are generally not life-threatening, they can still cause problems if they grow large enough to compromise kidney function or if they undergo malignant transformation.
Early detection and appropriate management of kidney neoplasms are crucial for improving patient outcomes and overall prognosis. Regular medical check-ups, imaging studies, and urinalysis can help in the early identification of these growths, allowing for timely intervention and treatment.
Antineoplastic agents are a class of drugs used to treat malignant neoplasms or cancer. These agents work by inhibiting the growth and proliferation of cancer cells, either by killing them or preventing their division and replication. Antineoplastic agents can be classified based on their mechanism of action, such as alkylating agents, antimetabolites, topoisomerase inhibitors, mitotic inhibitors, and targeted therapy agents.
Alkylating agents work by adding alkyl groups to DNA, which can cause cross-linking of DNA strands and ultimately lead to cell death. Antimetabolites interfere with the metabolic processes necessary for DNA synthesis and replication, while topoisomerase inhibitors prevent the relaxation of supercoiled DNA during replication. Mitotic inhibitors disrupt the normal functioning of the mitotic spindle, which is essential for cell division. Targeted therapy agents are designed to target specific molecular abnormalities in cancer cells, such as mutated oncogenes or dysregulated signaling pathways.
It's important to note that antineoplastic agents can also affect normal cells and tissues, leading to various side effects such as nausea, vomiting, hair loss, and myelosuppression (suppression of bone marrow function). Therefore, the use of these drugs requires careful monitoring and management of their potential adverse effects.
A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.
In the context of human anatomy, the term "tail" is not used to describe any part of the body. Humans are considered tailless primates, and there is no structure or feature that corresponds directly to the tails found in many other animals.
However, there are some medical terms related to the lower end of the spine that might be confused with a tail:
1. Coccyx (Tailbone): The coccyx is a small triangular bone at the very bottom of the spinal column, formed by the fusion of several rudimentary vertebrae. It's also known as the tailbone because it resembles the end of an animal's tail in its location and appearance.
2. Cauda Equina (Horse's Tail): The cauda equina is a bundle of nerve roots at the lower end of the spinal cord, just above the coccyx. It got its name because it looks like a horse's tail due to the numerous rootlets radiating from the conus medullaris (the tapering end of the spinal cord).
These two structures are not tails in the traditional sense but rather medical terms related to the lower end of the human spine.
Cell adhesion refers to the binding of cells to extracellular matrices or to other cells, a process that is fundamental to the development, function, and maintenance of multicellular organisms. Cell adhesion is mediated by various cell surface receptors, such as integrins, cadherins, and immunoglobulin-like cell adhesion molecules (Ig-CAMs), which interact with specific ligands in the extracellular environment. These interactions lead to the formation of specialized junctions, such as tight junctions, adherens junctions, and desmosomes, that help to maintain tissue architecture and regulate various cellular processes, including proliferation, differentiation, migration, and survival. Disruptions in cell adhesion can contribute to a variety of diseases, including cancer, inflammation, and degenerative disorders.
Thyroid neoplasms refer to abnormal growths or tumors in the thyroid gland, which can be benign (non-cancerous) or malignant (cancerous). These growths can vary in size and may cause a noticeable lump or nodule in the neck. Thyroid neoplasms can also affect the function of the thyroid gland, leading to hormonal imbalances and related symptoms. The exact causes of thyroid neoplasms are not fully understood, but risk factors include radiation exposure, family history, and certain genetic conditions. It is important to note that most thyroid nodules are benign, but a proper medical evaluation is necessary to determine the nature of the growth and develop an appropriate treatment plan.
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve pain, reduce inflammation, and decrease fever. It works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation in the body.
Etodolac is available in immediate-release and extended-release forms, and it can be taken orally as a tablet or capsule. It is typically used to treat conditions such as osteoarthritis, rheumatoid arthritis, and other types of joint pain and inflammation.
As with all medications, etodolac can have side effects, including stomach ulcers, bleeding, and kidney or liver problems. It should be used under the guidance of a healthcare provider, who can monitor for potential adverse effects and adjust the dosage as necessary. It is important to follow the instructions provided by the healthcare provider carefully when taking etodolac.
Angiogenesis inhibitors are a class of drugs that block the growth of new blood vessels (angiogenesis). They work by targeting specific molecules involved in the process of angiogenesis, such as vascular endothelial growth factor (VEGF) and its receptors. By blocking these molecules, angiogenesis inhibitors can prevent the development of new blood vessels that feed tumors, thereby slowing or stopping their growth.
Angiogenesis inhibitors are used in the treatment of various types of cancer, including colon, lung, breast, kidney, and ovarian cancer. They may be given alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy. Some examples of angiogenesis inhibitors include bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent), and pazopanib (Votrient).
It's important to note that while angiogenesis inhibitors can be effective in treating cancer, they can also have serious side effects, such as high blood pressure, bleeding, and damage to the heart or kidneys. Therefore, it's essential that patients receive careful monitoring and management of these potential side effects while undergoing treatment with angiogenesis inhibitors.
Up-regulation is a term used in molecular biology and medicine to describe an increase in the expression or activity of a gene, protein, or receptor in response to a stimulus. This can occur through various mechanisms such as increased transcription, translation, or reduced degradation of the molecule. Up-regulation can have important functional consequences, for example, enhancing the sensitivity or response of a cell to a hormone, neurotransmitter, or drug. It is a normal physiological process that can also be induced by disease or pharmacological interventions.
Hepatectomy is a surgical procedure that involves the removal of part or all of the liver. This procedure can be performed for various reasons, such as removing cancerous or non-cancerous tumors, treating liver trauma, or donating a portion of the liver to another person in need of a transplant (live donor hepatectomy). The extent of the hepatectomy depends on the medical condition and overall health of the patient. It is a complex procedure that requires significant expertise and experience from the surgical team due to the liver's unique anatomy, blood supply, and regenerative capabilities.
NM23 nucleoside diphosphate kinases are a group of proteins that play a role in regulating cellular functions, including signal transduction, cell proliferation, and differentiation. They are named after the NM23 gene that encodes them, which was initially identified as a potential metastasis suppressor.
NM23 nucleoside diphosphate kinases have the ability to transfer phosphate groups between nucleoside diphosphates (NDPs) and nucleoside triphosphates (NTPs), thereby maintaining the balance of these molecules in cells. This enzymatic activity is important for various cellular processes, such as DNA replication, repair, and transcription.
There are several isoforms of NM23 nucleoside diphosphate kinases, including NM23-H1, NM23-H2, and NM23-H4, which differ in their tissue distribution and functions. While the role of NM23 as a metastasis suppressor has been debated, recent studies suggest that it may be involved in regulating cell motility and invasion through its effects on actin dynamics and microtubule organization.
Overall, NM23 nucleoside diphosphate kinases are important regulators of cellular homeostasis and have been implicated in various physiological and pathological processes, including cancer metastasis, inflammation, and neurodegenerative diseases.
Circulating neoplastic cells (CNCs) are defined as malignant cancer cells that have detached from the primary tumor site and are found circulating in the peripheral blood. These cells have undergone genetic and epigenetic changes, leading to uncontrolled cell growth and division, and can form new tumors at distant sites in the body, a process known as metastasis.
The presence of CNCs has been shown to be a prognostic factor for poor outcomes in various types of cancer, including breast, colon, and prostate cancer. The detection and characterization of CNCs can provide valuable information about the tumor's biology, aggressiveness, and response to therapy, allowing for more personalized treatment approaches.
However, the detection of CNCs is challenging due to their rarity in the bloodstream, with only a few cells present among billions of normal blood cells. Therefore, highly sensitive methods such as flow cytometry, polymerase chain reaction (PCR), and next-generation sequencing are used for their identification and quantification.
Combined modality therapy (CMT) is a medical treatment approach that utilizes more than one method or type of therapy simultaneously or in close succession, with the goal of enhancing the overall effectiveness of the treatment. In the context of cancer care, CMT often refers to the combination of two or more primary treatment modalities, such as surgery, radiation therapy, and systemic therapies (chemotherapy, immunotherapy, targeted therapy, etc.).
The rationale behind using combined modality therapy is that each treatment method can target cancer cells in different ways, potentially increasing the likelihood of eliminating all cancer cells and reducing the risk of recurrence. The specific combination and sequence of treatments will depend on various factors, including the type and stage of cancer, patient's overall health, and individual preferences.
For example, a common CMT approach for locally advanced rectal cancer may involve preoperative (neoadjuvant) chemoradiation therapy, followed by surgery to remove the tumor, and then postoperative (adjuvant) chemotherapy. This combined approach allows for the reduction of the tumor size before surgery, increases the likelihood of complete tumor removal, and targets any remaining microscopic cancer cells with systemic chemotherapy.
It is essential to consult with a multidisciplinary team of healthcare professionals to determine the most appropriate CMT plan for each individual patient, considering both the potential benefits and risks associated with each treatment method.
Tumor suppressor proteins are a type of regulatory protein that helps control the cell cycle and prevent cells from dividing and growing in an uncontrolled manner. They work to inhibit tumor growth by preventing the formation of tumors or slowing down their progression. These proteins can repair damaged DNA, regulate gene expression, and initiate programmed cell death (apoptosis) if the damage is too severe for repair.
Mutations in tumor suppressor genes, which provide the code for these proteins, can lead to a decrease or loss of function in the resulting protein. This can result in uncontrolled cell growth and division, leading to the formation of tumors and cancer. Examples of tumor suppressor proteins include p53, Rb (retinoblastoma), and BRCA1/2.
Carcinoma, ductal, breast is a type of breast cancer that begins in the milk ducts (the tubes that carry milk from the lobules of the breast to the nipple). It is called "ductal" because it starts in the cells that line the milk ducts. Ductal carcinoma can be further classified as either non-invasive or invasive, based on whether the cancer cells are confined to the ducts or have spread beyond them into the surrounding breast tissue.
Non-invasive ductal carcinoma (also known as intraductal carcinoma or ductal carcinoma in situ) is a condition where abnormal cells have been found in the lining of the milk ducts, but they have not spread outside of the ducts. These cells have the potential to become invasive and spread to other parts of the breast or body if left untreated.
Invasive ductal carcinoma (IDC) is a type of breast cancer that starts in a milk duct and then grows into the surrounding breast tissue. From there, it can spread to other parts of the body through the bloodstream and lymphatic system. IDC is the most common form of breast cancer, accounting for about 80% of all cases.
Symptoms of ductal carcinoma may include a lump or thickening in the breast, changes in the size or shape of the breast, dimpling or puckering of the skin on the breast, nipple discharge (especially if it is clear or bloody), and/or redness or scaling of the nipple or breast skin. However, many cases of ductal carcinoma are detected through mammography before any symptoms develop.
Treatment for ductal carcinoma depends on several factors, including the stage and grade of the cancer, as well as the patient's overall health and personal preferences. Treatment options may include surgery (such as a lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, and/or targeted therapies.
Epithelial-mesenchymal transition (EMT) is a biological process that involves the transformation of epithelial cells into mesenchymal cells. This process is characterized by distinct changes in cell shape, behavior, and molecular markers.
Epithelial cells are typically tightly packed together and have a polarized structure with distinct apical and basal surfaces. In contrast, mesenchymal cells are elongated, spindle-shaped cells that can migrate and invade surrounding tissues.
During EMT, epithelial cells lose their polarity and cell-to-cell adhesion molecules, such as E-cadherin, and acquire mesenchymal markers, such as vimentin and N-cadherin. This transition enables the cells to become more motile and invasive, which is critical for embryonic development, wound healing, and cancer metastasis.
EMT is a complex process that involves various signaling pathways, including TGF-β, Wnt, Notch, and Hedgehog, among others. Dysregulation of EMT has been implicated in several diseases, particularly cancer, where it contributes to tumor progression, metastasis, and drug resistance.
Small interfering RNA (siRNA) is a type of short, double-stranded RNA molecule that plays a role in the RNA interference (RNAi) pathway. The RNAi pathway is a natural cellular process that regulates gene expression by targeting and destroying specific messenger RNA (mRNA) molecules, thereby preventing the translation of those mRNAs into proteins.
SiRNAs are typically 20-25 base pairs in length and are generated from longer double-stranded RNA precursors called hairpin RNAs or dsRNAs by an enzyme called Dicer. Once generated, siRNAs associate with a protein complex called the RNA-induced silencing complex (RISC), which uses one strand of the siRNA (the guide strand) to recognize and bind to complementary sequences in the target mRNA. The RISC then cleaves the target mRNA, leading to its degradation and the inhibition of protein synthesis.
SiRNAs have emerged as a powerful tool for studying gene function and have shown promise as therapeutic agents for a variety of diseases, including viral infections, cancer, and genetic disorders. However, their use as therapeutics is still in the early stages of development, and there are challenges associated with delivering siRNAs to specific cells and tissues in the body.
Osteosarcoma is defined as a type of cancerous tumor that arises from the cells that form bones (osteoblasts). It's the most common primary bone cancer, and it typically develops in the long bones of the body, such as the arms or legs, near the growth plates. Osteosarcoma can metastasize (spread) to other parts of the body, including the lungs, making it a highly malignant form of cancer. Symptoms may include bone pain, swelling, and fractures. Treatment usually involves a combination of surgery, chemotherapy, and/or radiation therapy.
Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.
Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.
Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.
Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.
Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).
The Western blotting procedure involves several steps:
1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.
Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.
A neoplasm is a tumor or growth that is formed by an abnormal and excessive proliferation of cells, which can be benign or malignant. Neoplasm proteins are therefore any proteins that are expressed or produced in these neoplastic cells. These proteins can play various roles in the development, progression, and maintenance of neoplasms.
Some neoplasm proteins may contribute to the uncontrolled cell growth and division seen in cancer, such as oncogenic proteins that promote cell cycle progression or inhibit apoptosis (programmed cell death). Others may help the neoplastic cells evade the immune system, allowing them to proliferate undetected. Still others may be involved in angiogenesis, the formation of new blood vessels that supply the tumor with nutrients and oxygen.
Neoplasm proteins can also serve as biomarkers for cancer diagnosis, prognosis, or treatment response. For example, the presence or level of certain neoplasm proteins in biological samples such as blood or tissue may indicate the presence of a specific type of cancer, help predict the likelihood of cancer recurrence, or suggest whether a particular therapy will be effective.
Overall, understanding the roles and behaviors of neoplasm proteins can provide valuable insights into the biology of cancer and inform the development of new diagnostic and therapeutic strategies.
The term "axilla" is used in anatomical context to refer to the armpit region, specifically the space located lateral to the upper part of the chest wall and medial to the upper arm. This area contains a number of important structures such as blood vessels, nerves, and lymph nodes, which play a critical role in the health and functioning of the upper limb. Understanding the anatomy of the axilla is essential for medical professionals performing various procedures, including surgeries and injections, in this region.
A metastasectomy is a surgical procedure to remove metastatic tumors, which are cancerous growths that have spread from the primary site of the cancer to other locations in the body. This procedure is typically performed when there is a reasonable expectation that all of the metastatic lesions can be removed, and it is often used in conjunction with other treatments such as chemotherapy or radiation therapy.
The goal of a metastasectomy is to improve the patient's prognosis by reducing the overall burden of cancer in their body. This may help to alleviate symptoms caused by the metastatic tumors, improve quality of life, and potentially increase survival time. However, the decision to perform a metastasectomy must be carefully weighed against the risks of surgery and other factors such as the patient's overall health and the extent of their cancer.
Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.
In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.
The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.
Membrane glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to their polypeptide backbone. They are integral components of biological membranes, spanning the lipid bilayer and playing crucial roles in various cellular processes.
The glycosylation of these proteins occurs in the endoplasmic reticulum (ER) and Golgi apparatus during protein folding and trafficking. The attached glycans can vary in structure, length, and composition, which contributes to the diversity of membrane glycoproteins.
Membrane glycoproteins can be classified into two main types based on their orientation within the lipid bilayer:
1. Type I (N-linked): These glycoproteins have a single transmembrane domain and an extracellular N-terminus, where the oligosaccharides are predominantly attached via asparagine residues (Asn-X-Ser/Thr sequon).
2. Type II (C-linked): These glycoproteins possess two transmembrane domains and an intracellular C-terminus, with the oligosaccharides linked to tryptophan residues via a mannose moiety.
Membrane glycoproteins are involved in various cellular functions, such as:
* Cell adhesion and recognition
* Receptor-mediated signal transduction
* Enzymatic catalysis
* Transport of molecules across membranes
* Cell-cell communication
* Immunological responses
Some examples of membrane glycoproteins include cell surface receptors (e.g., growth factor receptors, cytokine receptors), adhesion molecules (e.g., integrins, cadherins), and transporters (e.g., ion channels, ABC transporters).
Macrophages are a type of white blood cell that are an essential part of the immune system. They are large, specialized cells that engulf and destroy foreign substances, such as bacteria, viruses, parasites, and fungi, as well as damaged or dead cells. Macrophages are found throughout the body, including in the bloodstream, lymph nodes, spleen, liver, lungs, and connective tissues. They play a critical role in inflammation, immune response, and tissue repair and remodeling.
Macrophages originate from monocytes, which are a type of white blood cell produced in the bone marrow. When monocytes enter the tissues, they differentiate into macrophages, which have a larger size and more specialized functions than monocytes. Macrophages can change their shape and move through tissues to reach sites of infection or injury. They also produce cytokines, chemokines, and other signaling molecules that help coordinate the immune response and recruit other immune cells to the site of infection or injury.
Macrophages have a variety of surface receptors that allow them to recognize and respond to different types of foreign substances and signals from other cells. They can engulf and digest foreign particles, bacteria, and viruses through a process called phagocytosis. Macrophages also play a role in presenting antigens to T cells, which are another type of immune cell that helps coordinate the immune response.
Overall, macrophages are crucial for maintaining tissue homeostasis, defending against infection, and promoting wound healing and tissue repair. Dysregulation of macrophage function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions.
Chylothorax is a medical condition characterized by the accumulation of lymphatic fluid called chyle in the pleural space, which is the space between the lungs and the chest wall. Chyle is a milky-white fluid that contains nutrients, electrolytes, and immune cells, and it is normally transported through the thoracic duct to the bloodstream.
Chylothorax can occur due to various reasons, such as trauma, surgery, tumors, or congenital abnormalities that disrupt the normal flow of chyle. As a result, chyle leaks into the pleural space, causing symptoms such as cough, chest pain, difficulty breathing, and fever.
The diagnosis of chylothorax is usually made through imaging studies such as chest X-ray or CT scan, and confirmed by analyzing the fluid for the presence of chylomicrons, which are lipid particles found in chyle. The treatment options for chylothorax include dietary modifications, such as a low-fat diet with medium-chain triglycerides, chest tube drainage, and surgical interventions such as thoracic duct ligation or pleurodesis.
Disease-free survival (DFS) is a term used in medical research and clinical practice, particularly in the field of oncology. It refers to the length of time after primary treatment for a cancer during which no evidence of the disease can be found. This means that the patient shows no signs or symptoms of the cancer, and any imaging studies or other tests do not reveal any tumors or other indications of the disease.
DFS is often used as an important endpoint in clinical trials to evaluate the effectiveness of different treatments for cancer. By measuring the length of time until the cancer recurs or a new cancer develops, researchers can get a better sense of how well a particular treatment is working and whether it is improving patient outcomes.
It's important to note that DFS is not the same as overall survival (OS), which refers to the length of time from primary treatment until death from any cause. While DFS can provide valuable information about the effectiveness of cancer treatments, it does not necessarily reflect the impact of those treatments on patients' overall survival.
Cell growth processes refer to the series of events that occur within a cell leading to an increase in its size, mass, and number of organelles. These processes are essential for the development, maintenance, and reproduction of all living organisms. The main cell growth processes include:
1. Cell Cycle: It is the sequence of events that a eukaryotic cell goes through from one cell division (mitosis) to the next. The cell cycle consists of four distinct phases: G1 phase (growth and preparation for DNA replication), S phase (DNA synthesis), G2 phase (preparation for mitosis), and M phase (mitosis or meiosis).
2. DNA Replication: It is the process by which a cell makes an identical copy of its DNA molecule before cell division. This ensures that each daughter cell receives an exact replica of the parent cell's genetic material.
3. Protein Synthesis: Cells grow by increasing their protein content, which is achieved through the process of protein synthesis. This involves transcribing DNA into mRNA (transcription) and then translating that mRNA into a specific protein sequence (translation).
4. Cellular Metabolism: It refers to the sum total of all chemical reactions that occur within a cell to maintain life. These reactions include catabolic processes, which break down nutrients to release energy, and anabolic processes, which use energy to build complex molecules like proteins, lipids, and carbohydrates.
5. Cell Signaling: Cells communicate with each other through intricate signaling pathways that help coordinate growth, differentiation, and survival. These signals can come from within the cell (intracellular) or from outside the cell (extracellular).
6. Cell Division: Also known as mitosis, it is the process by which a single cell divides into two identical daughter cells. This ensures that each new cell contains an exact copy of the parent cell's genetic material and allows for growth and repair of tissues.
7. Apoptosis: It is a programmed cell death process that helps maintain tissue homeostasis by eliminating damaged or unnecessary cells. Dysregulation of apoptosis can lead to diseases such as cancer and autoimmune disorders.
Angiopoietin-2 (Ang-2) is a protein that is involved in the regulation of blood vessel formation and maintenance. It is a member of the angiopoietin family, which includes Ang-1, Ang-2, Ang-3, and Ang-4. These proteins bind to the Tie receptor tyrosine kinases (Tie1 and Tie2) on the surface of endothelial cells, which line the interior of blood vessels.
Ang-2 is primarily produced by endothelial cells and has context-dependent roles in angiogenesis, which is the growth of new blood vessels from pre-existing ones. In general, Ang-2 is thought to act as an antagonist of Ang-1, which promotes vessel stability and maturation.
Ang-2 can destabilize existing blood vessels by binding to Tie2 receptors and blocking the stabilizing effects of Ang-1. This can lead to increased vascular permeability and inflammation. However, in the presence of pro-angiogenic factors such as VEGF (vascular endothelial growth factor), Ang-2 can also promote the formation of new blood vessels by stimulating endothelial cell migration and proliferation.
Abnormal regulation of Ang-2 has been implicated in various diseases, including cancer, diabetic retinopathy, and age-related macular degeneration. In these conditions, increased levels of Ang-2 can contribute to the development of abnormal blood vessels, which can lead to tissue damage and loss of function.
Diagnostic imaging is a medical specialty that uses various technologies to produce visual representations of the internal structures and functioning of the body. These images are used to diagnose injury, disease, or other abnormalities and to monitor the effectiveness of treatment. Common modalities of diagnostic imaging include:
1. Radiography (X-ray): Uses ionizing radiation to produce detailed images of bones, teeth, and some organs.
2. Computed Tomography (CT) Scan: Combines X-ray technology with computer processing to create cross-sectional images of the body.
3. Magnetic Resonance Imaging (MRI): Uses a strong magnetic field and radio waves to generate detailed images of soft tissues, organs, and bones.
4. Ultrasound: Employs high-frequency sound waves to produce real-time images of internal structures, often used for obstetrics and gynecology.
5. Nuclear Medicine: Involves the administration of radioactive tracers to assess organ function or detect abnormalities within the body.
6. Positron Emission Tomography (PET) Scan: Uses a small amount of radioactive material to produce detailed images of metabolic activity in the body, often used for cancer detection and monitoring treatment response.
7. Fluoroscopy: Utilizes continuous X-ray imaging to observe moving structures or processes within the body, such as swallowing studies or angiography.
Diagnostic imaging plays a crucial role in modern medicine, allowing healthcare providers to make informed decisions about patient care and treatment plans.
Receptor Protein-Tyrosine Kinases (RTKs) are a type of transmembrane receptors found on the cell surface that play a crucial role in signal transduction and regulation of various cellular processes, including cell growth, differentiation, metabolism, and survival. They are called "tyrosine kinases" because they possess an intrinsic enzymatic activity that catalyzes the transfer of a phosphate group from ATP to tyrosine residues on target proteins, thereby modulating their function.
RTKs are composed of three main domains: an extracellular domain that binds to specific ligands (growth factors, hormones, or cytokines), a transmembrane domain that spans the cell membrane, and an intracellular domain with tyrosine kinase activity. Upon ligand binding, RTKs undergo conformational changes that lead to their dimerization or oligomerization, which in turn activates their tyrosine kinase activity. Activated RTKs then phosphorylate specific tyrosine residues on downstream signaling proteins, initiating a cascade of intracellular signaling events that ultimately result in the appropriate cellular response.
Dysregulation of RTK signaling has been implicated in various human diseases, including cancer, diabetes, and developmental disorders. As such, RTKs are important targets for therapeutic intervention in these conditions.
Gene expression profiling is a laboratory technique used to measure the activity (expression) of thousands of genes at once. This technique allows researchers and clinicians to identify which genes are turned on or off in a particular cell, tissue, or organism under specific conditions, such as during health, disease, development, or in response to various treatments.
The process typically involves isolating RNA from the cells or tissues of interest, converting it into complementary DNA (cDNA), and then using microarray or high-throughput sequencing technologies to determine which genes are expressed and at what levels. The resulting data can be used to identify patterns of gene expression that are associated with specific biological states or processes, providing valuable insights into the underlying molecular mechanisms of diseases and potential targets for therapeutic intervention.
In recent years, gene expression profiling has become an essential tool in various fields, including cancer research, drug discovery, and personalized medicine, where it is used to identify biomarkers of disease, predict patient outcomes, and guide treatment decisions.
Wuchereria bancrofti is a parasitic roundworm that causes lymphatic filariasis, also known as elephantiasis. It is transmitted to humans through the bite of infected mosquitoes. The worms infect the lymphatic system and can lead to chronic swelling of body parts such as the limbs, breasts, and genitals, as well as other symptoms including fever, chills, and skin rashes. Wuchereria bancrofti is a significant public health problem in many tropical and subtropical regions around the world.
Carcinoma, renal cell (also known as renal cell carcinoma or RCC) is a type of cancer that originates in the lining of the tubules of the kidney. These tubules are small structures within the kidney that help filter waste and fluids from the blood to form urine.
Renal cell carcinoma is the most common type of kidney cancer in adults, accounting for about 80-85% of all cases. It can affect people of any age, but it is more commonly diagnosed in those over the age of 50.
There are several subtypes of renal cell carcinoma, including clear cell, papillary, chromophobe, and collecting duct carcinomas, among others. Each subtype has a different appearance under the microscope and may have a different prognosis and response to treatment.
Symptoms of renal cell carcinoma can vary but may include blood in the urine, flank pain, a lump or mass in the abdomen, unexplained weight loss, fatigue, and fever. Treatment options for renal cell carcinoma depend on the stage and grade of the cancer, as well as the patient's overall health and preferences. Treatment may include surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy.
Head and neck neoplasms refer to abnormal growths or tumors in the head and neck region, which can be benign (non-cancerous) or malignant (cancerous). These tumors can develop in various sites, including the oral cavity, nasopharynx, oropharynx, larynx, hypopharynx, paranasal sinuses, salivary glands, and thyroid gland.
Benign neoplasms are slow-growing and generally do not spread to other parts of the body. However, they can still cause problems if they grow large enough to press on surrounding tissues or structures. Malignant neoplasms, on the other hand, can invade nearby tissues and organs and may also metastasize (spread) to other parts of the body.
Head and neck neoplasms can have various symptoms depending on their location and size. Common symptoms include difficulty swallowing, speaking, or breathing; pain in the mouth, throat, or ears; persistent coughing or hoarseness; and swelling or lumps in the neck or face. Early detection and treatment of head and neck neoplasms are crucial for improving outcomes and reducing the risk of complications.
Monoclonal murine-derived antibodies are a type of laboratory-produced antibody that is identical in structure, having been derived from a single clone of cells. These antibodies are created using mouse cells and are therefore composed entirely of mouse immune proteins. They are designed to bind specifically to a particular target protein or antigen, making them useful tools for research, diagnostic testing, and therapeutic applications.
Monoclonal antibodies offer several advantages over polyclonal antibodies (which are derived from multiple clones of cells and can recognize multiple epitopes on an antigen). Monoclonal antibodies have a consistent and uniform structure, making them more reliable for research and diagnostic purposes. They also have higher specificity and affinity for their target antigens, allowing for more sensitive detection and measurement.
However, there are some limitations to using monoclonal murine-derived antibodies in therapeutic applications. Because they are composed entirely of mouse proteins, they can elicit an immune response in humans, leading to the production of human anti-mouse antibodies (HAMA) that can neutralize their effectiveness. To overcome this limitation, researchers have developed chimeric and humanized monoclonal antibodies that incorporate human protein sequences, reducing the risk of an immune response.
Lymphoscintigraphy is a medical imaging technique that uses radioactive tracers to examine the lymphatic system, specifically the lymph nodes and vessels. In this procedure, a small amount of radioactive material is injected into the area of interest, usually an extremity or the site of a surgical incision. The tracer then travels through the lymphatic channels and accumulates in the regional lymph nodes. A specialized camera called a gamma camera detects the radiation emitted by the tracer and creates images that reveal the function and anatomy of the lymphatic system.
Lymphoscintigraphy is often used to diagnose and assess conditions affecting the lymphatic system, such as lymphedema, cancer metastasis to lymph nodes, or unusual lymphatic flow patterns. It can help identify sentinel lymph nodes (the first node(s) to receive drainage from a tumor) in patients with melanoma and breast cancer, which is crucial for surgical planning and staging purposes.
In summary, lymphoscintigraphy is a non-invasive imaging technique that utilizes radioactive tracers to visualize the lymphatic system's structure and function, providing valuable information for diagnostic and therapeutic decision-making in various clinical scenarios.
Microvessels are the smallest blood vessels in the body, including capillaries, venules, and arterioles. They form a crucial part of the circulatory system, responsible for delivering oxygen and nutrients to tissues and organs while removing waste products. Capillaries, the tiniest microvessels, facilitate the exchange of substances between blood and tissue cells through their thin walls. Overall, microvessels play a vital role in maintaining proper organ function and overall health.
A mouth neoplasm refers to an abnormal growth or tumor in the oral cavity, which can be benign (non-cancerous) or malignant (cancerous). Malignant mouth neoplasms are also known as oral cancer. They can develop on the lips, gums, tongue, roof and floor of the mouth, inside the cheeks, and in the oropharynx (the middle part of the throat at the back of the mouth).
Mouth neoplasms can have various causes, including genetic factors, tobacco use, alcohol consumption, and infection with human papillomavirus (HPV). Symptoms may include a lump or thickening in the oral soft tissues, white or red patches, persistent mouth sores, difficulty swallowing or speaking, and numbness in the mouth. Early detection and treatment of mouth neoplasms are crucial for improving outcomes and preventing complications.
Experimental neoplasms refer to abnormal growths or tumors that are induced and studied in a controlled laboratory setting, typically in animals or cell cultures. These studies are conducted to understand the fundamental mechanisms of cancer development, progression, and potential treatment strategies. By manipulating various factors such as genetic mutations, environmental exposures, and pharmacological interventions, researchers can gain valuable insights into the complex processes underlying neoplasm formation and identify novel targets for cancer therapy. It is important to note that experimental neoplasms may not always accurately represent human cancers, and further research is needed to translate these findings into clinically relevant applications.
Carcinoma, papillary is a type of cancer that begins in the cells that line the glandular structures or the lining of organs. In a papillary carcinoma, the cancerous cells grow and form small finger-like projections, called papillae, within the tumor. This type of cancer most commonly occurs in the thyroid gland, but can also be found in other organs such as the lung, breast, and kidney. Papillary carcinoma of the thyroid gland is usually slow-growing and has a good prognosis, especially when it is diagnosed at an early stage.
Lymphatic vessel tumors, also known as lymphangiomas, are benign (non-cancerous) tumors that develop from the lymphatic vessels. These tumors are made up of abnormal masses of dilated lymphatic vessels and can occur anywhere in the body, but they most commonly affect the head, neck, and axilla (armpit).
Lymphangiomas can be classified into three types based on their size and depth:
1. Capillary lymphangioma: This is a superficial type of lymphangioma that affects the skin and mucous membranes. It appears as a cluster of small, thin-walled vessels that are filled with clear fluid.
2. Cavernous lymphangioma: This is a deeper type of lymphangioma that affects the subcutaneous tissue. It appears as a mass of dilated lymphatic vessels that are filled with clear or milky fluid.
3. Cystic hygroma: This is a large, sac-like lymphangioma that affects the neck and armpit regions. It contains multiple cysts filled with clear or milky fluid.
Lymphangiomas are usually present at birth or develop during childhood. They may cause symptoms such as swelling, pain, infection, and difficulty swallowing or breathing if they affect the head and neck region. Treatment options for lymphatic vessel tumors include surgical excision, sclerotherapy (injection of a chemical agent to shrink the vessels), and laser therapy.
Splenic neoplasms refer to abnormal growths or tumors in the spleen, which can be benign (non-cancerous) or malignant (cancerous). These growths can arise from various cell types present within the spleen, including hematopoietic cells (red and white blood cells, platelets), stromal cells (supporting tissue), or lymphoid cells (part of the immune system).
There are several types of splenic neoplasms:
1. Hematologic malignancies: These are cancers that affect the blood and bone marrow, such as leukemias, lymphomas, and multiple myeloma. They often involve the spleen, causing enlargement (splenomegaly) and neoplastic infiltration of splenic tissue.
2. Primary splenic tumors: These are rare and include benign lesions like hemangiomas, lymphangiomas, and hamartomas, as well as malignant tumors such as angiosarcoma, littoral cell angiosarcoma, and primary splenic lymphoma.
3. Metastatic splenic tumors: These occur when cancer cells from other primary sites spread (metastasize) to the spleen. Common sources of metastasis include lung, breast, colon, and ovarian cancers, as well as melanomas and sarcomas.
Symptoms of splenic neoplasms may vary depending on the type and extent of the disease but often include abdominal pain or discomfort, fatigue, weight loss, and anemia. Diagnosis typically involves imaging studies (such as ultrasound, CT, or MRI scans) and sometimes requires a biopsy for confirmation. Treatment options depend on the type of neoplasm and may include surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy.
The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.
Cadherins are a type of cell adhesion molecule that play a crucial role in the development and maintenance of intercellular junctions. They are transmembrane proteins that mediate calcium-dependent homophilic binding between adjacent cells, meaning that they bind to identical cadherin molecules on neighboring cells.
There are several types of cadherins, including classical cadherins, desmosomal cadherins, and protocadherins, each with distinct functions and localization in tissues. Classical cadherins, also known as type I cadherins, are the most well-studied and are essential for the formation of adherens junctions, which help to maintain cell-to-cell contact and tissue architecture.
Desmosomal cadherins, on the other hand, are critical for the formation and maintenance of desmosomes, which are specialized intercellular junctions that provide mechanical strength and stability to tissues. Protocadherins are a diverse family of cadherin-related proteins that have been implicated in various developmental processes, including neuronal connectivity and tissue patterning.
Mutations in cadherin genes have been associated with several human diseases, including cancer, neurological disorders, and heart defects. Therefore, understanding the structure, function, and regulation of cadherins is essential for elucidating their roles in health and disease.
Granulation tissue is the pinkish, bumpy material that forms on the surface of a healing wound. It's composed of tiny blood vessels (capillaries), white blood cells, and fibroblasts - cells that produce collagen, which is a protein that helps to strengthen and support the tissue.
Granulation tissue plays a crucial role in the wound healing process by filling in the wound space, contracting the wound, and providing a foundation for the growth of new skin cells (epithelialization). It's typically formed within 3-5 days after an injury and continues to develop until the wound is fully healed.
It's important to note that while granulation tissue is a normal part of the healing process, excessive or overgrowth of granulation tissue can lead to complications such as delayed healing, infection, or the formation of hypertrophic scars or keloids. In these cases, medical intervention may be necessary to manage the excess tissue and promote proper healing.
Psoralea is a genus of plants in the legume family, Fabaceae. However, in a medical context, Psoralea seeds or fruits are sometimes referred to as a traditional herbal remedy in certain cultures. The seeds contain compounds with potential medicinal properties, such as psoralen, which can increase skin sensitivity to sunlight and have been used in the treatment of vitiligo, a condition that causes depigmentation of the skin.
It's important to note that the use of Psoralea seeds as a medical treatment is not widely accepted or studied in modern medicine, and they can have side effects, including nausea, vomiting, and increased risk of skin cancer with excessive sun exposure. Therefore, it should only be used under the guidance of a healthcare professional.
Muscle neoplasms are abnormal growths or tumors that develop in the muscle tissue. They can be benign (non-cancerous) or malignant (cancerous). Benign muscle neoplasms are typically slow-growing and do not spread to other parts of the body, while malignant muscle neoplasms, also known as soft tissue sarcomas, can grow quickly, invade nearby tissues, and metastasize (spread) to distant parts of the body.
Soft tissue sarcomas can arise from any of the muscles in the body, including the skeletal muscles (voluntary muscles that attach to bones and help with movement), smooth muscles (involuntary muscles found in the walls of blood vessels, digestive tract, and other organs), or cardiac muscle (the specialized muscle found in the heart).
There are many different types of soft tissue sarcomas, each with its own set of characteristics and prognosis. Treatment for muscle neoplasms typically involves a combination of surgery, radiation therapy, and chemotherapy, depending on the type, size, location, and stage of the tumor.
Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.
Examples of biological models include:
1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.
Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.
Radiosurgery is a non-invasive surgical procedure that uses precisely focused beams of radiation to treat various medical conditions, primarily in the field of neurosurgery and oncology. It allows for the destruction of targeted tissue while minimizing damage to surrounding healthy structures. Unlike traditional surgery, radiosurgery does not require any incisions, as it delivers radiation through the skin to reach the intended target.
The term "stereotactic" is often associated with radiosurgery, which refers to the use of a three-dimensional coordinate system to precisely locate and target the affected area. This technique enables high doses of radiation to be delivered accurately and efficiently, maximizing therapeutic effectiveness while minimizing side effects.
Radiosurgery can be used to treat various conditions such as brain tumors (both malignant and benign), arteriovenous malformations (AVMs), trigeminal neuralgia, acoustic neuromas, pituitary adenomas, and spinal cord tumors. Common radiosurgery platforms include the Gamma Knife, CyberKnife, and linear accelerator-based systems like Novalis Tx or TrueBeam.
It is essential to note that although it is called "surgery," radiosurgery does not involve any physical incisions or removal of tissue. Instead, it relies on the destructive effects of high-dose radiation to ablate or damage targeted cells over time, leading to their eventual death and resolution of symptoms or tumor control.
Down-regulation is a process that occurs in response to various stimuli, where the number or sensitivity of cell surface receptors or the expression of specific genes is decreased. This process helps maintain homeostasis within cells and tissues by reducing the ability of cells to respond to certain signals or molecules.
In the context of cell surface receptors, down-regulation can occur through several mechanisms:
1. Receptor internalization: After binding to their ligands, receptors can be internalized into the cell through endocytosis. Once inside the cell, these receptors may be degraded or recycled back to the cell surface in smaller numbers.
2. Reduced receptor synthesis: Down-regulation can also occur at the transcriptional level, where the expression of genes encoding for specific receptors is decreased, leading to fewer receptors being produced.
3. Receptor desensitization: Prolonged exposure to a ligand can lead to a decrease in receptor sensitivity or affinity, making it more difficult for the cell to respond to the signal.
In the context of gene expression, down-regulation refers to the decreased transcription and/or stability of specific mRNAs, leading to reduced protein levels. This process can be induced by various factors, including microRNA (miRNA)-mediated regulation, histone modification, or DNA methylation.
Down-regulation is an essential mechanism in many physiological processes and can also contribute to the development of several diseases, such as cancer and neurodegenerative disorders.
Lymphangiogenesis
Yihai Cao
Vascular endothelial growth factor C
Lymphangioleiomyomatosis
MMP2
C-fos-induced growth factor
VEGFR-2 inhibitor
Michael Jeltsch
Lymphovascular invasion
Vascular endothelial growth factor
LYVE1
SEMA7A
Lymphatic system
Tumor microenvironment
Lymphangiogenesis - Wikipedia
LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C | Nature...
Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting...
KAKEN - Research Projects | Roles of prostanoids in facilitation of lymphangiogenesis and lymph node metastasis (KAKENHI...
JCI - Emerging roles of lymphatic endothelium in regulating adaptive immunity
VEGFD vascular endothelial growth factor D [Homo sapiens (human)] - Gene - NCBI
Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
Lymphangiogenesis as a Prognostic Marker in Breast Cancer Using D2-40 as Lymphatic Endothelial Marker-A Preliminary Study
Abstract NG02: Lymphatic vessels: Balancing immune priming and immune evasion in melanoma | Cancer Research | American...
Diane R. Bielenberg, PhD - DF/HCC
Amgen Highlights Data To Be Presented At 2013 European Cancer Congress| Amgen
IJMS | Free Full-Text | Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
Early-onset colorectal cancer: Current insights and future directions
EVOTEC ENTERS PARTNERSHIP WITH KAZIA THERAPEUTICS FOR CLINICAL DEVELOPMENT OF EVT801 - CheckOrphan
LYVE1 Protein | CRSBP-1 Peptide | LYVE-1 Antigen | ProSpec
Marlys H Witte | UA Profiles
JCI - Adipocyte-derived endotrophin promotes malignant tumor progression
Satoshi Kashiwagi - Google Scholar
Búsqueda | Portal Regional de la BVS
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. - Immunology
Cancer Biology Faculty | School of Medicine
Steele Labs :: Lab Base :: Pi Bio
Cdk5 and Foxc2 - a new relationship in the lymphatic vasculature | Oncotarget
Anti-tumour and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis
RFA-DK-18-021: Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed)
RNA interference and receptors - IBMC
January 2019 - DNA Topoisomerase - Synthesis and Structure-activity
October | 2018 | Hormones Signaling
Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions<...
Stabilin-2 and Cancer Metastasis | Encyclopedia MDPI
Vessels57
- Lymphangiogenesis is the formation of lymphatic vessels from pre-existing lymphatic vessels in a method believed to be similar to angiogenesis (blood vessel development). (wikipedia.org)
- Therefore, this complex regulatory network requires precise control of gene expression patterns at both transcriptional and post-transcriptional levels in order to ensure proper maturation, differentiation, and formation of blood and lymphatic vessels. (nature.com)
- Lymphatic vasculature forms a network of vessels that drain interstitial fluid from tissues and return this fluid to the blood. (nii.ac.jp)
- Lymphangiogesis, the formation of lymphatic vessels from preexisting lymphatic vessels, plays an important role in homeostasis of interstitial fluids and immunity. (nii.ac.jp)
- Our appreciation for the varied functions of lymphatic vessels has evolved from different scientific disciplines. (jci.org)
- Traditionally, microcirculatory physiologists studied the essential transport functions of lymphatic vessels in removing fluid, molecules, and cells after leaking from blood vessels in the periphery and before returning them to the blood circulation. (jci.org)
- Immunologists recognized the importance of lymphatic vessels as channels for leukocyte trafficking from peripheral sites to their draining LNs ( 4 - 6 ), and as conduits for soluble antigens that can be taken up directly by LN-resident B cells and immature DCs ( 7 - 10 ), which help regulate the kinetics of antigen presentation. (jci.org)
- These new ideas, in turn, reveal a paradigm whereby the transport and immune functions of lymphatic vessels, which were previously considered separately, are in fact intimately coupled. (jci.org)
- While we particularly focus on LEC interactions with DCs and T cells, we also highlight features that support immune regulation, including the structure and function of lymphatic vessels and the compartmentalization of the LN stroma, which help control the manner in which LECs can interface with immune cells. (jci.org)
- The lymphatic vessels and secondary lymphoid organs (SLOs) are arranged in a manner that optimizes interactions among antigens, APCs, and innate and adaptive effector cells. (jci.org)
- Absence of Lymphangiogenesis and Intratumoural Lymph Vessels in Human Metastatic Breast Cancer," The Journal of Pathology, Vol. 200, 2003, pp. 195-206. (scirp.org)
- While lymphatic vessels provide an important route for disseminating tumor cells, they are also a crucial interface between a developing malignancy and the host immune response. (aacrjournals.org)
- Rather than acting as passive conduits, lymphatic vessels directly regulate their transport function and facilitate leukocyte trafficking for efficient induction of adaptive immunity in downstream draining lymph nodes. (aacrjournals.org)
- We recently published that in the absence of dermal lymphatic vessels, the tumor microenvironment of murine melanoma remains completely uninflamed and fails to induce a robust T-cell response (1). (aacrjournals.org)
- We therefore hypothesize that lymphatic vessels are (A) required for induction of adaptive immunity but (B) acquire immunosuppressive activity as a function of the accumulation of local cytotoxic immunity. (aacrjournals.org)
- There are two main routes by which tumor cells disseminate, through blood vessels (hematogenous spread) and through lymphatic vessels (lymphogenous spread). (harvard.edu)
- Therapies targeted against lymphangiogenesis, the growth of new lymphatic vessels, are beginning to be explored. (harvard.edu)
- Members of the vascular endothelial growth factor (VEGF) family, including VEGF-A and VEGF-C, stimulate the growth of blood vessels and lymphatic vessels. (harvard.edu)
- A common receptor expressed on both adult blood vessels and lymphatic vessels is neuropilin 2 (NRP2). (harvard.edu)
- In vivo, mock-transfected tumors are circumscribed with many large, open-lumened lymphatic vessels and contain intratumoral lymphatic vessels as well, while tumors overexpressing SEMA3F do not contain lymphatic vessels or have dilated surrounding lymphatics. (harvard.edu)
- The angiopoietins are also involved in lymphangiogenesis, the formation of new lymphatic vessels, which plays a key role in tumor metastasis. (amgen.com)
- Its primary activity is to inhibit lymphangiogenesis, the formation of new lymphatic vessels around a growing tumour. (checkorphan.org)
- LYVE1 is mainly found in the endothelial cells that line lymphatic vessels. (prospecbio.com)
- When acting as a transporter for HA, LYVE1 can take on various roles, including moderating the uptake for catabolism within the lymphatic endothelial cells or delivering HA into the lumen of lymphatic vessels for reuptake in the lymph nodes. (prospecbio.com)
- Although it is clear that dissemination via the blood system involves hemangiogenesis, it is uncertain whether tumors also induce lymphangiogenesis or simply invade existing peritumoral vessels. (ox.ac.uk)
- To address the issue we quantitated tumor lymph vessels in archival specimens of head and neck cancer by immunostaining for the recently described lymphatic endothelial marker LYVE-1, the vascular endothelial marker CD34, and the pKi67 proliferation marker, correlating lymph vessel density and proliferation index with clinical and pathological variables. (ox.ac.uk)
- We also found that NO mediates lymph-angiogenesis and metastasis as well as function of lymphatic vessels. (harvard.edu)
- We recently uncovered that restoration of perivascular NO gradients improves structure and function of both blood and lymphatic vessels, and response to radiation. (harvard.edu)
- Our study elucidates cyclin dependent kinase 5 (Cdk5) as an essential player in the development of lymphatic vessels. (oncotarget.com)
- Primary lymphatic vessels remodel into blind ending lymphatic capillaries that take up interstitial fluid and collecting lymphatic vessels that contain valves, are covered by smooth muscle cells and drain the lymph into the venous system [ 2 ]. (oncotarget.com)
- However, studies with the major focus on immune mechanisms, role of lymphatics in cancer metastasis and study of lymphatic vessels in organs other than those from the digestive system will not be considered responsive. (nih.gov)
- Lymphatic vessels perform critical roles in organ functions, yet their roles in health and disease are poorly understood and understudied. (nih.gov)
- In the digestive system, lymphatic vessel function is interwoven with organ function, both anatomically and physiologically and these vessels lie at the nexus of critical hormonal, digestive and immune functions. (nih.gov)
- Lymphatic vessels within different organs and in different physiological and pathological processes show a remarkable plasticity and heterogeneity, reflecting their functional specialization. (nih.gov)
- Many of these functions include key roles of lymphatic vessels, yet the roles of lymphatics, the character of the vessels in the intestinal environment and key regulators of lymphatic function in intestinal health and disease remain understudied. (nih.gov)
- Nrp2 is a promising target for inhibition because it is highly expressed in lymphatic vessels. (elsevierpure.com)
- Invasion of lymphatic vessels is a key step in the metastasis of primary tumors to draining lymph nodes. (ox.ac.uk)
- Angiogenesis (the formation of new blood vessels) and lymphangiogenesis (formation of new lymphatic vessels), i.e., neovasculogenesis, are key determinants for the survival, proliferation, and metastasis of cancer cells. (toppersonalhealth.com)
- Increased formation of new blood and lymphatic vessels in the liver. (toppersonalhealth.com)
- The main interests of the Dr. Alitalo's group is to understand the mechanisms of development of blood vessels from preexisting ones in a process called angiogenesis and to learn analogous mechanisms of lymphangiogenesis. (euroacadti.eu)
- They currently study angiogenesis and lymphatic vessels particularly in malignant tumors, focusing on the growth factor-receptor signaling and growth factor-mediated endothelial cell reprogramming. (euroacadti.eu)
- MTC metastasizes through blood or lymphatic vessels. (fapesp.br)
- Spread can occur by local invasion into the surrounding tissue, by systemic metastasis via tumor-associated blood vessels to distant organs, or by lymphatic metastasis via tumor-associated lymphatic vessels to draining sentinel lymph nodes, then to distal lymph nodes and from there to distant organs. (dermatologytimes.com)
- Dr. Detmar notes, 'It is tempting to speculate that the lymphangiogenic factors, in addition to increasing the mass of tumor-associated lymphatic vessels, might activate the lymphatic endothelium to express increased amounts of chemokines or adhesion molecules and receptors, which are involved in tumor cell-LEC interactions, thereby actively contributing to cancer dissemination. (dermatologytimes.com)
- In the cardiovascular system, the heart pumps new blood vessels and of lymphatic vessels from preexisting the blood through arteries into smaller arterioles and into ones, are involved in a number of physiological and patho- capillary beds. (sagepub.com)
- e lymphatic network is composed of blind- in�ammation, increased blood �ow as a conse�uence of beginning thin-walled capillaries without pericyte coverage vesseldilationandedemaformationduetoincreasedperme- and with incomplete basal lamina as well as of collecting ability of the blood vessels. (sagepub.com)
- However, this therapeutic regimen for ischemic limb using ADRCs did not affect remote melanoma growth nor the density of its feeder artery, angiogenesis and lymphatic vessels compared to the PBS group. (nagoya-u.ac.jp)
- E.g. in lymphedema patients suffer from swollen limbs because lymphatic vessels are absent or not functioning properly. (jeltsch.org)
- And the spread of cancer ("metastasis") seems to be intimately related to the lymphatic system as the cancer cells use the lymphatic vessels as pathways to travel within the body. (jeltsch.org)
- It is obvious that many diseases could be treated if we would be able to influence the growth of both blood and lymphatic vessels. (jeltsch.org)
- Our laboratory works on growth factors, that regulate the development and function of blood vessels and lymphatic vessels. (jeltsch.org)
- All lymphatic vessels arise by angiogenesis. (jeltsch.org)
- The first lymphatic vessels sprout from the venous compartment of the circulatory system. (jeltsch.org)
- The only known growth factor, that stimulates the growth of lymphatic vessels was cloned in our laboratory: VEGF-C. VEGF-C binds to VEGF receptor-2 and VEGF receptor-3 (VEGFR-3). (jeltsch.org)
- Administration of VEGF Trap, a receptor-based fusion protein that binds and neutralizes VEGF-A but not VEGF-C or -D, completely inhibited both hemangiogenesis and the outgrowth of LYVE-1(+) lymphatic vessels following injury. (ox.ac.uk)
- Lymphatic vessels form from pre-existing vessels via lymphangiogenesis in both development and in pathological settings. (edu.au)
- A potential diagnostic pitfall is the presence of vascular metastasis in the intracapsular lymphatic vessels of the node, which mimics capsular nevi. (medscape.com)
Tumors10
- How tumors access and spread via the lymphatics is not understood. (ox.ac.uk)
- Moreover, the lymphatic system contributes to tumor cell metastasis - tumors induce lymphangiogenesis to allow the dissemination of tumor cells [ 3 ]. (oncotarget.com)
- kidney, angiogenesis (CD31-positive cells), lymphangiogenesis (LYVE-1-positive cells), and TAM (F4/80-positive cell) numbers in the tumors of LM8-bearing mice. (complementaryoncology.com)
- criteria are the absence of extrahepatic metastasis and vascular invasion identifiable with preoperative images, a solitary tumor of 5 cm or less, or if there are multiple tumors, three or fewer tumors measuring 3 cm or less in diameter at a maximum (Milan criteria) (LF005401 level 2a). (hormonessignaling.com)
- Using experiments involving transgenic mice, they have successfully shown that dietary saturated/trans fats, but not cholesterol, can trigger hepatic angiogenesis and lymphangiogenesis, leading to the promotion of hepatic tumors. (toppersonalhealth.com)
- Dr. Detmar and his team of researchers conducted a study consisting of 45 patients with primary cutaneous melanoma, where the extent of tumor lymphangiogenesis in the excised primary tumors and the presence of metastases in the sentinel lymph node biopsy samples were examined. (dermatologytimes.com)
- Results showed that prominent 'hot spots' of increased lymphatic vessel density were seen in the primary melanomas of patients whose tumors had metastasized to the sentinel lymph nodes, as compared to nonmetastatic tumors. (dermatologytimes.com)
- Dr. Detmar postulates that metastatic melanomas can therefore be characterized by increased lymphangiogenesis, as compared to non-metastatic tumors, and that the degree of tumor lymphangiogenesis can serve as a novel predictor of lymph node metastasis and overall patient survival, independent of tumor thickness. (dermatologytimes.com)
- In 1995, we demonstrated the prognostic importance of lymphatic invasion in rectal cancer and advocated the subdivision of stage III (Dukes' C) tumors according to lymphatic invasion ( 12 ). (iiarjournals.org)
- 2005). Lymphangiogenesis is also important for tumors expansion, especially the for lymph node metastasis (Kadowaki et al . (vin.com)
Vasculature4
- Lymphatic vasculature development" (PDF). (wikipedia.org)
- This unequivocal requirement for a functional lymphatic vasculature in the priming of cutaneous immunity further supports the prediction that LVD may be a novel biomarker of immune reactivity within tumor parenchyma. (aacrjournals.org)
- Dysfunction of the lymphatic vasculature results in lymphedema formation and compromises immune function. (oncotarget.com)
- Here we have addressed the question by comparing the RNA profiles of primary lymphatic endothelial cells (LEC) isolated from the vasculature of normal tissue and from highly metastatic T-241/vascular endothelial growth factor (VEGF)-C fibrosarcomas implanted in C57BL/6 mice. (ox.ac.uk)
Endothelium2
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries: Podoplanin as a Specific Marker for Lymphatic Endothelium," American Journal of Pathology, Vol. 154, 1999, pp. 385-394. (scirp.org)
- Our recent study elucidates the serine-threonine kinase cyclin dependent kinase 5 (Cdk5) as the missing link in the regulation of Foxc2 in the lymphatic endothelium [ 12 ]. (oncotarget.com)
Pathological5
- Impaired or excessive lymphatic vessel formation has been implicated in a number of pathological conditions including neoplasm metastasis, oedema, rheumatoid arthritis, psoriasis, lymphangiomatosis and impaired wound healing. (wikipedia.org)
- We studied tumour lymphangiogenesis and lymphatic invasion using D2-40 endothelial marker in 35 breast cancer patients treated by primary surgery and correlated it with various clinico-pathological prognostic parameters. (scirp.org)
- VEGF-C functions in both physiological and pathological lymphangiogenesis, particularly in tumor metastasis, making it an attractive therapeutic target. (elsevierpure.com)
- Both the ligand and receptor are usually co-expressed at sites of lymphatic vessel sprouting, in the embryo, and in various pathological conditions. (bio-techne.com)
- We conclude that VEGF-A recruitment of monocytes/macrophages plays a crucial role in inducing inflammatory neovascularization by supplying/amplifying signals essential for pathological hemangiogenesis and lymphangiogenesis. (ox.ac.uk)
VEGF25
- The role of the lymphatic system in these diseases has received renewed interest largely due to the discovery of lymphatic endothelial cell (LEC)-specific markers such as podoplanin, LYVE-1, PROX1, desmoplakin and VEGF-C receptor VEGFR-3. (wikipedia.org)
- There are several known pro-lymphangiogenesis inducers such as VEGF-C, hyaluronic acid and ephrin-B2. (wikipedia.org)
- The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. (nih.gov)
- VEGF messenger RNA (mRNA) is widely overexpressed in tissues and is associated with metastasis, recurrence, and prognosis [ 2 ]. (hindawi.com)
- Tumour growth and metastasis are associated with angiogenesis and lymphangiogenesis through the production of vascular endothelial growth factor (VEGF) or VEGF-C in tumours, and the phosphorylation of VEGF receptor (VEGFR)-2 or VEGFR-3 in vascular endothelial cells or lymphatic endothelial cells (LECs). (complementaryoncology.com)
- Wogonin had no effect on VEGF-C production in LM8 cells, or VEGFR-3 expression in human lymphatic endothelial cells (HLECs), however, it inhibited VEGF-C-induced VEGFR-3 phosphorylation in HLECs. (complementaryoncology.com)
- The anti-tumour and anti-metastatic actions of wogonin may be associated with the inhibition of VEGF-C-induced lymphangiogenesis through a reduction in VEGF-C-induced VEGFR-3 phosphorylation by the inhibition of COX-2 expression and IL-1? (complementaryoncology.com)
- Vascular endothelial growth factor-C (VEGF-C) is a secreted growth factor essential for lymphangiogenesis. (elsevierpure.com)
- Our previous studies show that activation of the VEGF-C/VEGFR-3 axis promotes cancer metastasis and is associated with clinical progression in patients with lung cancer, indicating that VEGFR-3 is a potential target for cancer therapy. (oncotarget.com)
- VEGF-C interactions with VEGF R3 are critical for lymphangiogenesis. (bio-techne.com)
- Over-expression of VEGF-C in tumor cells induces tumoral lymphatic hyperplasia, neoangiogenesis, and vessel sprouting, resulting in enhanced lymph flow and metastasis to regional lymph nodes. (bio-techne.com)
- According to Prof. Tanaka , "We demonstrated for the first time that hepatic angiogenesis and lymphangiogenesis were enhanced by saturated-fat- or trans-fat-rich diets, but not cholesterol-rich diets, mainly through the JNK-HIF1α-VEGF-C axis. (toppersonalhealth.com)
- Most significantly, they have found that VEGF-C over-expression leads to lymphangiogenesis, intralymphatic tumor growth and lymph node metastasis in several tumor models. (euroacadti.eu)
- Despite the fact that it is well-known that Vascular Endothelial Growth Factor (VEGF) binds to its receptor VEGFR and initiates endothelial cell proliferation, almost nothing is known about their involvement and mechanisms in the process of MTC metastasis.Interestingly, RET (RET/PTC) gene rearrangement, present in papillary thyroid carciomas, modulates the expression of many genes that could be involved on tumor growth and angiogenesis, such as CXCL12 and CXCR4. (fapesp.br)
- It is also known that Tumor-Associated Macrophages (TAM) are attracted by CXCL12 and VEGF, and can promote angiogenesis and tumor metastasis. (fapesp.br)
- Therefore, we propose to investigate p.G533C mutation on gene RET associated to inherited MTC genesis modulating different VEGF isoforms, VEGFR, and other mediators involved on the process of angiogenesis and lymphangiogenesis on tumor progression. (fapesp.br)
- The elevated expression of several angiogenic factors, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF) and interleukin-8, has been detected in primary cutaneous melanomas, and the importance of these mediators in promoting melanoma angiogenesis and metastasis has been confirmed in tumor xenotransplant models. (dermatologytimes.com)
- e lymphatic blood vascular endothelial cells are activated by several in�ammatory mediators (e.g., vascular endothelial growth capillariestakeupthisprotein-rich�uid,therebymaintaining factor- (VEGF-)A, tumor necrosis factor (TNF-) , inter- not only tissue �uid homeostasis but also exerting immune leukin (IL)-6, and IL-1), leading to the typical signs of surveillance. (sagepub.com)
- VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. (ox.ac.uk)
- Lymphangiogenesis, an important initial step in tumor metastasis and transplant sensitization, is mediated by the action of VEGF-C and -D on VEGFR3. (ox.ac.uk)
- We re-evaluated the potential role of VEGF-A in lymphangiogenesis using a novel model in which both lymphangiogenesis and hemangiogenesis are induced in the normally avascular cornea. (ox.ac.uk)
- Furthermore, both lymphangiogenesis and hemangiogenesis were significantly reduced in mice transgenic for VEGF-A(164/164) or VEGF-A(188/188) (each of which expresses only one of the three principle VEGF-A isoforms). (ox.ac.uk)
- Because VEGF-A is chemotactic for macrophages and we demonstrate here that macrophages in inflamed corneas release lymphangiogenic VEGF-C/VEGF-D, we evaluated the possibility that macrophage recruitment plays a role in VEGF-A-mediated lymphangiogenesis. (ox.ac.uk)
- VEGF is one of most important mediators of neoplastic angiogenesis and lymphangiogenesis (Hirakawa et al . (vin.com)
- It should be noted that studies of lymphatic vessel growth utilizing protein reagents or transgenic technology alone, in a tissue/cell culture environment, during tumor metastasis, in a lymphatic disease paradigm, or during tissue repair, have shown that various growth factors, such as platelet-derived growth factor BB (1), hepatocyte growth factor (2), fibroblast growth factor (3), and VEGF-A (4) appear to play a role. (arizona.edu)
Tumour Lymphangiogenesis2
- Suppression of Tumour Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling," Journal of the National Cancer Institute, Vol. 94, No. 11, 2002, pp. 819-825. (scirp.org)
- Tumour-associated macrophages (TAMs) play an important role in tumour lymphangiogenesis, and consequently stimulate metastasis through the lymphatic system to lymph nodes. (complementaryoncology.com)
Blood vascular endothelial cells2
- We determine a comprehensive map of lineage-specific lncRNAs in human dermal lymphatic and blood vascular endothelial cells (LECs and BECs), combining RNA-Seq and CAGE-Seq. (nature.com)
- ICAM-)1, vascular cell adhesion molecule- (VCAM-)1, elargestcollectinglymphaticvessel,thethoracicduct,con- and E-selectin on activated blood vascular endothelial cells, nects the lymphatic system with the cardiovascular system. (sagepub.com)
Lymph node metastases2
- A study in which the investigators injected PC3M-LN4 prostate cancer cells that are known to be rich in pericellular HA in mice, found that when Stabilin-2 was blocked with a blocking antibody prior to tumor injection, the number of lymph node metastases was dramatically reduced [ 7 ] . (encyclopedia.pub)
- A follow-up human patient study in the evaluation of tongue cancer supports this finding in which the potential of solid tumor lymph node metastases is positively correlated with Stabilin-2 expression in lymph node [ 8 ] . (encyclopedia.pub)
Altered lymphatic vessel1
- Although the process is enhanced by tumor lymphangiogenesis, it is unclear whether this is a consequence of increased lymphatic vessel number, altered lymphatic vessel properties, or both. (ox.ac.uk)
Regulator of lymphatic2
- Thereafter, a distinct subpopulation of endothelial cells lining the cardinal vein starts differentiating by expressing the TF PROX1, the master regulator of lymphatic endothelial cell (LEC) identity, via the TFs SOX18 and COUPTFII. (nature.com)
- In summary, our study elucidates the Cdk5-Foxc2 interaction as a critical regulator of lymphatic vessel development. (oncotarget.com)
Differentiation1
- Age and sex of patients, site, gross type, size (maximum tumor diameter), preoperative serum level of carcinoembryonic antigen (CEA), depth of wall invasion, status of lymph node metastasis, histopathological differentiation, degree of lymphatic and venous invasion, and presence or absence of postoperative adjuvant chemotherapy were extracted from operation records and pathology reports. (iiarjournals.org)
Receptor5
- EVT801 is a pre-clinical-stage, orally available, small molecule inhibitor of the lymphatic growth factor receptor VEGFR3, originally developed within Evotec's partnership with Sanofi. (checkorphan.org)
- LYVE1, also known as lymphatic vessel endothelial receptor 1 or lymphatic vessel endothelial hyaluronic acid receptor 1, is a member of the link protein family, which has the capability to bind with hyaluronic acid. (prospecbio.com)
- Moreover, we show similar induction of ESAM, Endoglin, and leptin receptor within tumor lymphatics in a series of human head and neck and colorectal carcinomas, and uncover a dramatic correlation between ESAM expression and nodal metastasis that identifies this marker as a possible prognostic indicator. (ox.ac.uk)
- Vascular endothelial growth factor receptor 3 (VEGFR-3) supports tumor lymphangiogenesis. (oncotarget.com)
- Says Prof. Tanaka, "Long-term feeding of SFA and TFA diets to HCVcpTg mice increased the expressions of vascular endothelial cell indicators like CD31 and TEK receptor tyrosine kinase, in addition to lymphatic vessel endothelial hyaluronan receptor 1. (toppersonalhealth.com)
Distant metastases2
- Melanoma is the most lethal skin cancer with most deaths occurring from distant metastases. (harvard.edu)
- In addition, no distant metastases were detected in any of the mice regardless the group. (nagoya-u.ac.jp)
Invasion10
- Prognostic Value of Lymphatic and Blood Vessel Invasion in Neuroendocrine Tumours of the Lung," The American Journal of Surgical Pathology, Vol. 29, 2005, pp. 324-328. (scirp.org)
- These findings reveal a remarkable degree of phenotypic plasticity in cancer lymphatics and provide new insight into the processes of lymphatic invasion and lymph node metastasis. (ox.ac.uk)
- Aim: To determine correlations between lymphatic invasion and lymph node metastasis or disease stage, and clarify the prognostic impact of lymphatic invasion. (iiarjournals.org)
- Lymphatic invasion was calculated as an average and the degree was also determined (Ly0-3). (iiarjournals.org)
- Clinicopathological factors including lymphatic invasion were assessed by uni- and multivariate analyses to determine factors affecting survival. (iiarjournals.org)
- Survival was compared between different degrees of lymphatic invasion and lymph node metastasis. (iiarjournals.org)
- Conclusion: Lymphatic invasion in colorectal cancer correlates well with the status of lymph node metastasis and disease stage, representing an independent prognostic factor after curative resection. (iiarjournals.org)
- Lymphatic invasion can be used for evaluating tumor aggressiveness and estimating patient survival, irrespective of the actual number of positive lymph nodes found. (iiarjournals.org)
- It is well-known that not only the presence or absence of lymph node metastasis, but also the degree of presence, is an important prognostic factor, along with depth of tumor invasion, and is useful in determining the adjuvant chemotherapy and surveillance program ( 3 , 4 ). (iiarjournals.org)
- The present study examined correlations between lymphatic invasion and lymph node metastasis or disease stage, and clarified the prognostic impact of lymphatic invasion, based on a large series and long-term follow-up of patients with colorectal cancer curatively treated. (iiarjournals.org)
Inflammatory3
- Ongoing research in this area is essential to understanding how inflammatory lymphangiogenesis affects both cancer progression as well as chronic inflammation that leads to autoimmunity. (jci.org)
- I continue to work on a variety of infectious diseases and immune disorders (e.g., inflammatory bowel disease, AIDS, Kaposi sarcoma, tuberculosis, filariasis, congenital/hereditary lymphatic system syndromes, opportunistic infections/neoplasms) and direct an internationally recognized Lymphedema-Angiodysplasia clinic. (arizona.edu)
- The lymphatic system plays an important role in uptake of dietary fat and clearance of cholesterol from peripheral tissues and has been implicated in several disease states such as obesity, metabolic syndrome and inflammatory bowel disease (IBD). (nih.gov)
LECs2
- Emerging research on the roles of stromal cells in modulating adaptive immune responses has included a new focus on lymphatic endothelial cells (LECs). (jci.org)
- Lymphatic endothelial cells (LECs) themselves have been shown to play active roles in controlling their transport functions and in directly communicating with immune cells to modulate their immediate and downstream functions. (jci.org)
Prognostic Marker2
- M. A. Ansari, V. Pandey, V. Srivastava, M. Kumar, R. Mishra and A. Kumar, "Lymphangiogenesis as a Prognostic Marker in Breast Cancer Using D2-40 as Lymphatic Endothelial Marker-A Preliminary Study," Journal of Cancer Therapy , Vol. 3 No. 5A, 2012, pp. 814-821. (scirp.org)
- He explains that the extent of tumor lymphangiogenesis is a highly sensitive (83 percent) and specific (89 percent) prognostic marker of lymph node metastasis. (dermatologytimes.com)
Progression1
- Lymphatic vessel remodeling and lymphangiogenesis is correlated with melanoma progression and lymph node metastasis. (aacrjournals.org)
Mice2
- Yoshiyuki Kimura & Maho Sumiyoshi examined the effects of wogonin isolated from Scutellaria baicalensis roots on tumour growth and metastasis using a highly metastatic model in osteosarcoma LM8-bearing mice. (complementaryoncology.com)
- We characterise molecular mechanisms that control lymphangiogenesis using model organisms (zebrafish and mice). (edu.au)
Immunity4
- Lymphangiogenesis plays an important physiological role in homeostasis, metabolism and immunity. (wikipedia.org)
- Consistently, TCGA analysis of human cutaneous metastatic melanoma identified positive correlations between LEC gene expression and immune genes, including a T cell-inflamed signature, indicating a relationship between lymphatic vessel remodeling and local immunity. (aacrjournals.org)
- To test the first part of this hypothesis (A), we have continued our published work and used a cutaneous model of viral infection to demonstrate the requirement for lymphatic vessel drainage in cutaneous immunity. (aacrjournals.org)
- The lymphatic system is a crucial component of nutrient and hormone absorption, fluid homeostasis and immunity. (nih.gov)
Drainage2
- My translational interests and contributions have spanned blood/lymphatic vascular endothelial cell biology and pathobiology in vitro and in vivo, hepatosplanchnic lymphatic/microcirculatory physiology, small animal models, in vivo lymphatic imaging, thoracic duct lymph drainage, lymphogenous cancer spread, and genomics/proteomics of lymphedema-angiodysplasia syndromes in man and experimental models, including defects, deficiency, and overexpression of human and murine lymphangio- gene-sis genes and their syndromic/phenotypic manifestations. (arizona.edu)
- A sentinel lymph node (SLN) is the first lymph node or group of nodes to receive lymphatic drainage from a tumor at a particular anatomic area. (medscape.com)
Circulatory system3
- In contrast, lymphatic vasculogenesis starts after the establishment of the blood circulatory system. (nature.com)
- Lymphatic vessel formation starts after the circulatory system has been established by specification of lymphatic endothelial cells from preexisting embryonic veins. (oncotarget.com)
- The lymphatic system or "second circulatory system" is a common transportation highway for metastases and tumor lymphangiogenesis and is common among the various types of cancer. (encyclopedia.pub)
Dissemination2
- The lymphatic system is an important route for cancer dissemination, and lymph node metastasis (LNM) serves as a critical prognostic determinant in cancer patients. (nii.ac.jp)
- Lymphatic vessel dysfunction is associated with various pathologic conditions, including immunologic disorders, lymphedema, as well as tumor dissemination. (oncotarget.com)
System10
- The lymphatic system is essential for the maintenance of tissue fluid homeostasis, enables the uptake of dietary lipids and regulates the immune response by serving as a trafficking route for immune cells [ 1 ]. (oncotarget.com)
- Malfunctioning of the lymphatic system is associated with various pathologic conditions. (oncotarget.com)
- The purpose of this FOA is to invite applications that investigate aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system. (nih.gov)
- Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in this system and its organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest. (nih.gov)
- esides the increased in�amma- tory cell in�ltration into the in�amed tissue, it has become In vertebrates, there are two vascular systems: the cardio- clearintherecentyearsthatacuteandchronicin�ammatory vascular and the lymphatic system. (sagepub.com)
- Apart from the cardiovascular system there is another vascular system: the lymphatic system. (jeltsch.org)
- Similar to the cardiovascular function, the lymphatic system plays an important role in several diseases. (jeltsch.org)
- The lymphatic system develops later than the cardiovascular system. (jeltsch.org)
- Since its first sequential visualization in 1902 by Florence Sabin, the development and maintenance of the lymphatic system has intrigued scientists and clinicians worldwide. (arizona.edu)
- This article is a commentary on the usefulness of specific genetic engineering tools in understanding the development of the lymphatic system-with a focus on the questions that have been addressed using these tools, the extent to which the questions have actually been answered, and the questions that have subsequently been raised. (arizona.edu)
Lymphedema1
- We found that lymphangiogenesis in chronic inflammation and secondary lymphedema was regulated by COX-2. (nii.ac.jp)
Biological2
- These biological phenomena occur by angiogenesis and lymphangiogenesis, respectively. (fapesp.br)
- It is not meant to be a discussion of protein reagents or of specific biological situations that exhibit lymphangiogenesis (see reviews 5-7). (arizona.edu)
Melanoma4
- Furthermore, our previous work demonstrated that vascular endothelial growth factor C (VEGFC)-driven lymphangiogenesis in the context of murine melanoma drove increased leukocyte infiltration but associated with poor CD8+ T cell priming in draining lymph nodes (4). (aacrjournals.org)
- Recently we have demonstrated that one member of the class 3 semaphorins, Semaphorin 3F (SEMA3F), can inhibit human melanoma metastasis. (harvard.edu)
- Melanoma researchers have therefore been concentrating their efforts on learning more about angiogenesis, lymphangiogenesis and the nature of metastasis in order to better understand which types of melanomas have a tendency to metastasize. (dermatologytimes.com)
- Dr. Detmar set out to investigate whether the extent of tumor lymphangiogenesis can predict melanoma metastasis to sentinel lymph nodes. (dermatologytimes.com)
Intratumoral3
- Furthermore, others have recently demonstrated that lymphatic vessel density (LVD) in combination with intratumoral T cell function stratified best overall survival in nonmetastatic and metastatic colorectal cancer (2). (aacrjournals.org)
- Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. (ox.ac.uk)
- P = 0.017), but no obvious correlation with intratumoral lymphatics. (ox.ac.uk)
Marker1
- A number of studies have also flagged LYVE1 as a marker for lymphoid tissue and lymphangiogenesis. (prospecbio.com)
Vessel development2
- Yet, the knowledge about the regulation of lymphatic vessel development is still limited. (oncotarget.com)
- The forkhead transcription factor Foxc2 plays a central role in lymphatic vessel development and lymphatic valve formation [ 4 - 6 ]. (oncotarget.com)
Tissue3
- LYVE1 has also been found to play a role in HA localisation to the surface of the endothelial cells that line the lymphatic tissue. (prospecbio.com)
- In conclusion, local implantation of ADRCs promotes angiogenesis in response to tissue ischemia in the hind limb without promoting remote tumor growth and related angio/lymphangiogenesis. (nagoya-u.ac.jp)
- Lymphatics function to drain tissue fluid and traffic immune cells, but are also utilised by tumours to metastasise to lymph nodes and secondary sites in cancer. (edu.au)
Density1
- Lymphangiogenesis was quantified using lymphatic micro vessel density (LMVD) by counting the immunostained lymphatic microvessels at 200X. (scirp.org)
Immune2
- Following cutaneous vaccinia infection we demonstrate that in the absence of lymphatic vessel transport, both cellular and humoral adaptive immune responses fail to initiate, leading to enhanced cutaneous immunopathology and persistent viral load. (aacrjournals.org)
- As well as being involved in HA degradation and transportation, studies indicate that HA localisation towards lymphatic surfaces, which is linked to LYVE1, can affect the body's immune responses and tumour metastases. (prospecbio.com)
Cancer9
- Lymphangiogenesis in Cancer Metastasis. (wikipedia.org)
- High LYVE-1-Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer," Clinical Cancer Research, Vol. 10, No. 21, 2004, pp. 7144-7149. (scirp.org)
- Absence of Functional Lymphatics within a Murine Sarcoma: A Molecular and Functional Evaluation," Cancer Research, Vol. 60, No. 16, 2000, pp. 4324-4327. (scirp.org)
- Metastasis is the most common cause of death in cancer patients. (harvard.edu)
- Deciphering the mechanisms underlying increased risk of brain metastases in young women with triple negative breast cancer. (cuanschutz.edu)
- Moreover, Foxc2 has been associated with cancer cell metastasis and epithelial-mesenchymal transition [ 9 , 10 ]. (oncotarget.com)
- This is especially relevant for the liver sinusoids and lymph nodes which express high levels of Stabilin-2 and also are sites of metastases for a number of cancer types. (encyclopedia.pub)
- Background: The degree of lymph node metastasis represents an important prognostic factor for cancer. (iiarjournals.org)
- Although the prognostic import of lymph node metastasis is widely accepted in colorectal cancer, 12 nodes or more must be examined to adequately assess the degree of lymph node metastasis ( 5 , 6 ). (iiarjournals.org)